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CHAPTER 1: SUMMARY 
In the early 2000s, a catheter-based device known as the Evalve was designed to 
clip the mitral valve (MV) leaflets together at the site of mitral regurgitation (MR), treating 
MR without requiring open-heart surgery. This device is now known as MitraClip (Abbott 
Vascular, Santa Clara, CA), and, with over 45,000 patients treated worldwide, it is 
currently the only widely-used and FDA approved transcatheter mitral repair device. 
MitraClip is a catheter-delivered device designed to grasp and approximate the 
mitral leaflets, closing the regurgitant orifice and treating MR. MR reduction to <2+ is 
critical to achieve optimal patient outcomes, and additional clips may be deployed to reach 
this level of MR reduction. However, by nature, the device also reduces MV Area (MVA) 
and may increase mean MV gradient (MVG). These two metrics are the key descriptors of 
Mitral Stenosis (MS), according to clinical guidelines. Indeed, a limitation of MitraClip 
treatment is the undesirable creation of MS. Recently published clinical reports have shown 
that significantly poorer long-term patient outcomes result when a patient is left with a 
mean MVG above 5 mmHg. When treating MR with MitraClip, the benefits of MR 
reduction must be balanced with concomitant risk of increased MS severity as additional 
clips are implanted. A “compromise” between complete elimination of MR and significant 
reduction of MVA due to placement of additional clips may occur, resulting in an aborted 
clip strategy.  
Limited clinical evidence has suggested that, under certain conditions, severity of 
MS after MitraClip may be further exacerbated by diastolic restriction of the anterior mitral 
leaflet (AML) caused by severe dilatation of the left ventricle (LV) and papillary muscle 
 xvi 
(PM) displacement. This LV remodeling is characteristic of functional mitral regurgitation 
(FMR). MitraClip is currently not approved in the US for treatment of FMR, but, only in 
degenerative mitral regurgitation (DMR). However, due to lack of other treatment options, 
MitraClip is widely-used off-label for treatment of FMR. 
The purpose of this study was to determine the conditions under which MitraClip 
may create Mitral Stenosis (MS) in the setting of AML tethering. Using the Georgia Tech 
left heart simulator, MitraClip placement was simulated using a custom clip (GTclip) with 
dimensions identical to MitraClip. One or two GTclips were placed in common locations 
on excised ovine MV samples (N=6), and AML tethering severity was varied from mild to 
severe for each of the GTclip placements. Mitral annular area (MAA) was varied for each 
MV sample, from 3.6 cm2 to 4.8 cm2. 
AML tethering severity was found to be a highly significant factor increasing MVG 
and decreasing MVA (p<0.001). When GTclip placement was simulated in the presence 
of severe AML tethering, mean MVG>5mmHg resulted more frequently than with GTclip 
placement alone (46% v. 4%, respectively). However, at MAA above 4.7 cm2, severe AML 
tethering did not cause moderate MS (placement of up to two GTclips, 95% confidence). 
Here, baseline MVA was near the established minimum for MitraClip treatment 
(3.9±0.3cm2). This first-of-its-kind study will provide valuable information on MitraClip 
performance, aiding cardiologists patient selection and in determining the suitability of 
different MitraClip treatments for the large population of FMR patients. 
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CHAPTER 2: BACKGROUND AND INTRODUCTION 
2.1 Valvular Disease and Mitral Regurgitation 
Valvular heart disease (VHD) is estimated to affect 2.5% of the population in 
industrialized countries, and the prevalence of VHD increases drastically in elderly 
populations.1 Mitral regurgitation (MR) is the most common valvular disease; moderate 
levels of MR are found in 6.4% of the population between 65 and 74 years of age, and 
9.3% of the population over 75 years of age.2 
MR can be subdivided into two main categories; degenerative MR (DMR) is a disease 
of the tissue of the mitral valve (MV) itself, while functional MR (FMR) is a secondary 
effect of a disease in the left ventricle (LV) or surroundings of the MV.3  In FMR, 
remodeling of the papillary muscles (PMs) and mitral annulus cause MV insufficiency.4 
Though the geometric distortions vary widely, PM displacement, annular dilatation, and 
leaflet tethering are widely accepted as the causes of FMR.5, 6 The effects of these disease 
etiologies can be summarized using Carpentier’s functional classifications of leaflet 
performance.3 Type I classification refers to MR with normal leaflet motion, and is seen 
with leaflet perforations or annular dilatation. Type II refers to excess leaflet motion or 
prolapse and occurs in the presence of chordal/PM rupture or elongation (DMR). Finally, 
type III function refers to restricted leaflet opening and/or closing, and is often seen in the 
presence of excess LV remodeling and disease (FMR). Regardless of the underlying 
etiology, MR may result in pulmonary hypertension, dyspnea, and atrial dysfunction, 
among other complications.5  
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2.2 Treatment of MR 
To treat symptomatic MR, the MV structures are either repaired, or the MV is replaced 
altogether. As a result of the complexity of the mitral valve (Figure 2-1), many novel repair 
techniques have been developed. These techniques include annuloplasty, chordal 
replacements, papillary muscle shortening or adjustments, leaflet resections, among many 
other options.7  
 
Figure 2-1 – Components and complexity of the mitral valve (MV). A schematic of 
the MV with labelled components is shown in (A) (Modified from Carpentier et al.3) 




Due to low perioperative mortality, and excellent long-term survival rates, surgical 
repair is the gold standard for DMR, and is an effective option for treating FMR.8-10 In 
FMR patients, a restrictive annuloplasty is often used to down-size the dilated annulus and 
bring the leaflets back into coaptation. However, recurrence of MR following restrictive 
annuloplasty is a persistent clinical problem.4 Studies of these patients have shown that LV 
sphericity, continued PM displacement and leaflet tethering are strong predictors of MR 
recurrence.4, 11 These studies illustrate the importance of MV subvalvular apparatus 
geometry to leaflet function and repair durability. 
Directly targeting the mitral leaflets, the Alfieri stitch, or edge-to-edge (E2E) repair 
is a surgical technique for treatment of MR (Figure 2-2A). Introduced in the early 1990’s 
by Alfieri and colleagues12, the E2E repair involves approximating the leaflet edges at the 
site of regurgitation, creating a double orifice in the mitral position. Because the E2E repair 
does not address ventricular remodeling, it was originally intended for DMR patients, and 
was often accompanied with annuloplasty for repair stabilization.12, 13 Indeed, the E2E 
repair was useful only in certain situations, and often in combination with other repairs. 
Until recently, it was marketed as another useful “addition to the surgical armamentarium 
in mitral valve reconstruction.”13, 14 Regardless of the repair tool(s) used, invasive, open-
heart surgery with cardiopulmonary bypass was traditionally a requirement. 
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Figure 2-2 – The Alfieri stitch and MitraClip. The original edge-to-edge surgical 
repair technique, known as the Alfieri stitch is shown in (A) (modified from Feldman 
et al15 and Rogers et al16). A device known as MitraClip was designed to replicate the 
repair percutaneously (B). Under echo guidance, the device is deployed on the beating 
heart as shown in (C). 
2.3 Advent of MitraClip and Transcatheter Mitral Valve Repair 
Many patients with MR in the older population subgroups have co-morbidities and are 
considered high risk for open heart surgery. In a recent study, among patients with severe 
symptomatic MR, a decision not to operate was made for 49% of the patients.17 The 
percentage increases significantly in older populations, and in patients with low left 
ventricular ejection fraction, meaning that a large population of individuals with MR are 
simply untreatable.17 The need for solutions to treat these high-risk patients has inspired a 
host of new minimally invasive endovascular repair devices.7 In the early 2000’s, a 
catheter-based device known as the Evalve was designed to replicate the E2E repair 
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without invasive and risky open heart surgery, thereby opening up a new population of 
patients for MR treatment.18 This device is now known as MitraClip  (Abbott Vascular, 
Santa Clara, CA), and is currently the only widely-used and FDA approved transcatheter 
mitral repair device (Figure 2-2B).  
MitraClip is an MRI compatible, catheter-delivered cobalt-chromium device. Two 
grippers grasp and approximate the edges of the anterior and posterior mitral leaflets, 
creating the double-orifice characteristic of the E2E repair. Using both TEE and biplane 
fluoroscopy for navigation, the device is positioned inside the left atrium of the beating 
heart directly above the target clip location (Figure 2-2C).19 It is then advanced through the 
valve into the LV, and the grippers are opened fully. The MitraClip grippers are then 
steadily closed as the device is pulled back toward valve, in order to grasp both leaflets. 
Closing the MitraClip system further approximates the mitral leaflets and seals the 
regurgitant orifice. After delivery of the device, the operator will evaluate the resulting MR 
levels according to clinical guidelines.20 Per those guidelines, if MR reduction to ≤2+ is 
not achieved following initial clip implantation, an additional clip may be implanted. 
2.4 Indicated and Off-Label MitraClip Usage 
MitraClip indications for use (IFU) denote a narrow range of patients amenable to the 
treatment (Figure 2-3). The IFU indicates that the device is only to be used in degenerative 
MR for Type I or Type II leaflet motion. Furthermore, only patients with central MR where 
posterior leaflet length ≥ 10 mm, mitral valve area (MVA) > 4 cm2, coaptation depth < 11 
mm and coaptation length > 2 mm are deemed amenable to MitraClip.19, 21 However, 
because the device has very low rates of adverse events, and is still the only treatment 
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option for many patients, it is being widely used in Europe, and off-label in the US, to treat 
FMR with varying degrees of success.16, 21-23 Additionally, as many as four devices have 
been implanted in a single patient in Europe.24 It is clear that the device is now being 
creatively used to treat a multitude of more complex leaflet functions and anatomies, but 
the two of the biggest limitations appear to be MitraClip detachment, and undesired 
development of mitral stenosis (MS),25 or blockage of forward flow through the mitral 
valve.16 
 
Figure 2-3 – Patient characteristics amenable to MitraClip. Coaptation and 
regurgitant orifice geometries from the IFU are shown in (A) and leaflet function 
types are shown in (B). (modified from Feldman et al15 and Rogers et al16) 
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2.5 Engineering Analysis of MitraClip and Edge-to-Edge Repair Function 
Since its inception, numerous in vitro and in silico analyses of MitraClip and E2E 
repair have been conducted to understand both the biomechanical impact of the repair on 
the leaflet tissue, and the hemodynamic impact on flow through the MV in diastole.26 First, 
in vitro left heart simulators have been applied to study the force imparted to the E2E repair 
across the cardiac cycle,27, 28 as well as the effectiveness of E2E repair in the setting of 
displaced PMs (Figure 2-4A).29 These studies have shown that force on the repair is 
generally larger in systole, and larger in the setting of annular dilatation.27, 28 Repair 
effectiveness in reducing MR was generally worse in the setting of FMR with annular 
dilation and PM displacement.29, 30 Similar in vivo investigations have corroborated a 
greater force on the repair with annular dilatation, but have found peak force to occur in 
peak diastole, which could be caused by dynamic annular dilatation.31, 32 These findings 
can be applied to understand the mechanics of MitraClip detachment and/or tissue stress. 
However, the studies were performed only on single central repair placement, and 
generally in larger MV samples, where creation of MS was highly unlikely. In a recent 
study by Sturla and colleagues, MitraClip was implanted in ex vivo porcine hearts, and 
mean diastolic MV gradient (MVG) was measured as a function of heart rate to quantify 
MS.33 Mean MVG was found to increase as a function of heart rate, however, due to the 
size of the porcine MV samples, no significant MS was observed. 
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Figure 2-4 – Computational and in vitro analysis of edge-to-edge (E2E) repair and 
MitraClip. Force transducers have been used to study the loading imparted to the 
E2E repair by the leaflets in vitro (A). Fluid structure interactive models have been 
used to assess fluid flow through the MV after E2E repair (B). Finally, stress and 
strain in the mitral leaflets has been measured following full and partial MitraClip 
grasping (C). Modified from (A) Jimenez et al28, (B) Lau et al34, and (C) Sturla et al.33 
 Computational models have been applied to further understand the stress in the MV 
leaflets following E2E repair (Figure 2-4B,C). Starting in the late 1990’s, Kunzelman and 
colleagues performed structural analysis on idealized MV geometries, simulating MV 
closure, PM displacement, annuloplasty, and chordal replacement techniques.35-37 Shortly 
thereafter, Alfieri, Maisano, Votta and colleagues used structural computational modeling 
to simulate the E2E repair technique and investigate stress in the MV under conditions of 
annular dilatation, systolic pressure, and diastolic pressure.38, 39 These structural studies 
show that the stress on the MV leaflets is related to the dilatation of the MV annulus, and 
that two distinct loading peaks are imparted on the leaflets: one at peak systole, and one at 
peak diastole.38 More recently, fluid-structure interactive models have been applied to 
understand the flow of fluid through the MV in diastole, when E2E repair is simulated 
(Figure 2-4B). Lau and colleagues have shown an increase in mitral inflow velocity and a 
reduction in MVA after central E2E repair simulation.34 
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2.6 Treating Mitral Regurgitation Without Causing Mitral Stenosis 
The central focus of benchtop and computational models has been the leaflet force 
on the E2E repair and MitraClip, and the stress in the leaflets. However, the elevation of 
MVG and reduction of MVA leading to the undesired creation of MS is a clinically 
acknowledged risk in certain cases.16, 25, 40, 41 A recently published report by Neuss et al has 
shown that significantly poorer long-term patient outcomes result when a patient is left 
with a mean MVG above 5 mmHg after MitraClip implantation.40, 42 On the other hand, 
reduction of MR to <2+ is also critical to achieve optimal patient outcomes.43 Additional 
clips may be deployed to reach this level of MR reduction, but the benefits of MR reduction 
and concomitant risk of increased MS severity with each clip must be balanced.40 In 
general, additional clips are not placed if mean MVG is found to be ≥ 4 mmHg.44 Relevant 
thresholds for MS severity45, along with the threshold for placing additional clips are 
summarized in Table 2-1. 
Table 2-1 – Mitral Stenosis (MS) cutoff values. Mild, moderate and severe values from 
guidelines, and cutoff values for additional clip placement from clinical experience 
are shown. MVA – MV area; MVG – MV gradient 
Level MVA (cm2) Mean MVG (mmHg) 
Cutoff: Place 
another Clip? >2.5 <4 
Mild MS >1.5 <5 
Moderate MS 1.0-1.5 5-10 
Severe MS <1.0 >10 
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Though undesirable creation of MS may be a consequence of MitraClip therapy, 
well established guidelines and practices are currently in-place to avoid such a result.40, 44 
For example, as per the MitraClip IFU and pivotal US clinical trials (EVEREST I,II), MR 
patients with baseline MVA<4.0 cm2 are contraindicated for MitraClip treatment.15 Further 
supporting this, Herrmann and colleagues have confirmed that MitraClip repair in patients 
with a baseline MVA above this cutoff did not result in significant MS when implanting 
up to two devices.46  
2.7 Challenges of Treating Functional Mitral Regurgitation with MitraClip 
It is important to note that the above guidelines are well established in patients with 
DMR.19 Contrary to DMR, MitraClip is currently not approved in the US for treatment of 
FMR. In FMR, severe dilatation of the LV and PM displacement can cause diastolic 
restriction (Type III) of the anterior mitral leaflet (AML), complicating use of leaflet based 
interventions such as MitraClip.47 A recent study by Chan et al illustrates that use of 
MitraClip in the setting of AML tethering can cause elevated mean MVG under certain 
conditions. The authors report that there is often a “compromise” between complete 
elimination of MR and significant increase in mean MVG due to placement of additional 
clips, and the planned clip strategy must be aborted.48 This compromise was most often 
observed in patients with FMR, rather than DMR. Furthermore, in this small group of 12 
patients with FMR, the authors found that compromise occurred most often in those 
patients with more AML tethering. 
It is clear that baseline MVA and number of clips implanted can affect the 
likelihood of inducing MS. Additionally, leaflet tethering commonly seen in FMR appears 
 11 
to be an important factor affecting resultant MS severity, but our understanding of the 
effects of MitraClip in the setting of AML tethering is still incomplete. A quantitative 
description of the impact of baseline MVA, MitraClip placement, and severity of AML 
tethering on resulting MS severity would provide useful information toward patient 




CHAPTER 3: HYPOTHESIS AND SPECIFIC AIMS 
MitraClip (Abbott Vascular, Santa Clara, California) is currently not approved in the US 
for treatment of functional mitral regurgitation (FMR), but is widely used off-label for this 
purpose. In many cases, multiple MitraClip devices are used to treat MR43 though 
placement of additional devices can further reduce mitral valve area (MVA) and increase 
of mean mitral valve gradient (MVG), leading to mitral stenosis (MS).45 In FMR in 
particular, MS severity after MitraClip may be further exacerbated by diastolic restriction 
of the anterior mitral leaflet (AML) caused by severe dilatation of the left ventricle (LV) 
and papillary muscle (PM) displacement 48. However, limited data on the effect of AML 
tethering on MVA and MVG after MitraClip exists. The central hypothesis of this study is 
that obstruction of flow through the mitral valve will be exacerbated by both 
MitraClip placement and by restriction of the AML during diastole, and that a 
greater incidence of MS will be observed when both factors are present than with 
either alone. This could provide useful information toward patient selection for treatment 
with transcatheter edge-to-edge MV repair devices. 
Specific Aim 1: Develop a left heart simulator capable of repeatable, precise diastolic 
AML tethering, and a custom edge-to-edge clip device (GTclip) for use in SA2. To 
directly test the hypothesis, methods of repeatably controlling and measuring AML 
tethering on excised ovine MV samples must first be developed. Secondly, a custom edge-
to-edge clip (GTclip) will be developed. This device will model the bite dimensions and 
profile of the MitraClip device, allowing MitraClip implantation to be simulated. 
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Specific Aim 2: Use the tools developed in SA1 to assess MV forward flow obstruction 
as a function of baseline MV annular area, AML tethering severity, and positioning 
of GTclip devices. The severity of MS is expected to vary as a factor of MV annular area, 
AML tethering severity, and placement of GTclips. On each MV sample, placement of one 
or two GTclips will be performed in common locations. AML tether severity will be varied 
among three levels for each GTclip placement. Baseline mitral annular area will be varied 
from sample to sample. Quantification of MS severity as a function of these factors will 
yield useful information toward patient selection for treatment with transcatheter edge-to-
edge MV repair devices. 
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CHAPTER 4: MATERIALS AND METHODS 
4.1 Left Heart Simulation Platform 
4.1.1 Left Heart Simulator Components and Operation 
The GT Left Heart Simulator (GTLHS) (Figure 4-1) consists of a clear acrylic left 
atrium and ventricle. A pulsatile piston pump (Vivitro Labs, Inc. Victoria, BC, Canada) 
drove flow through the system, and systemic resistance/compliance elements were 
manually adjusted to achieve physiological pressures and flow over the cardiac cycle (heart 
rate – 70 beats/min, cardiac output – 5 L/min, peak LV pressure – 120 mmHg, 35% systole, 
65% diastole). While typical MitraClip patients may have significantly reduced pre-
procedural cardiac output (CO) due to regurgitant fractions as high as 50%, their post-
procedural CO is regularly found to be in the range of 5 L/min. Therefore, the mitral inflow 
volume was held constant at 70 mL (5 L/min). Wall-tapped pressure transducers (Utah 
Medical, Midvale, UT, USA) were used to record pressure in the left atrium and ventricle, 
while an electromagnetic flow probe (Carolina Medical, East Bend, NC, USA) was used 
to record instantaneous flow rate. A Philips iE33 xMatrix quantitative echo system and X7-
2 transducer (Philips Healthcare, Andover, MA, USA) were used to acquire 3D gated echo 
images and measure MVA. 
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Figure 4-1 – Georgia Tech Left Heart Simulator (GTLHS) platform. The complete 
GTLHS pulse-duplicator is shown in (A), where a piston pump drives flow, opening 
and closing the MV physiologically. The excised and mounted ovine MV is shown in 
(B), where the papillary muscles (PMs) are tethered. GTLHS chamber components 
are illustrated in (C) where the symmetric PM displacement vectors used to create 
anterior mitral leaflet (AML) tethering are shown in red. The left atrium and 
ventricle (LA and LV) of the GTLHS are also denoted. 
4.1.2 Papillary Muscle Rod Control 
Papillary muscles (PMs) were affixed to 1/4” stainless-steel rods for positional 
control and anterior leaflet tethering. The rods were mounted through ball-in-socket joints 
on the apical plate of the GTLHS (Figure 4-1). The PM position was controlled in three 
dimensions by manually manipulating the PM rods on the exterior of the GTLHS. 
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4.1.3 Adjustable Annulus Design and Construction 
A custom adjustable annulus plate was constructed to control the baseline mitral 
annular area (MAA) for MV samples (Figure 4-3). As opposed to MAA, MVA is the area 
of the MV at its most narrow point, and is typically used to assess suitability of patients for 
MitraClip. With normal diastolic leaflet function, MAA and MVA may be comparable, 
however, Kubota and colleagues have shown that severe leaflet tethering may significantly 
reduce MVA.49 The range of MAA values used in this study was 3.6 to 4.8 cm2, in order 
to account for the effect of leaflet tethering on MVA reduction. This was intended to create 
baseline MVA values of 4.0±0.5 cm2. This range was targeted, because patients with 
baseline MVA just above or below the minimum MVA of 4.0cm2 may be more prone to 
MS following MitraClip than patients with higher baseline MVA.46 Nevertheless, patients 
with baseline MVA in this range are commonly treated with the device in a real-world 
setting.46, 48 
The custom adjustable annulus plate was designed and assembled as follows. A 5.0 
cm2 annular profile was first laser-cut from an elastic neoprene skirt, and from a rigid PETG 
plastic sheet (McMaster-Carr part no. 1580T3 and 9513K82, respectively). The elastic 
neoprene skirt was then sutured to the perimeter of the plastic sheet (Figure 4-2). Next, a 
stainless-steel wire was imbedded in the suture cuff surrounding the annulus using a Ford 
interlocking stitch, such that tension applied to the wire constricted the annulus to as small 
as 3.6 cm2.  
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Figure 4-2 – Adjustable annulus plate design and assembly. The base of the plate (left) 
is machined from acrylic, and interfaces with the left atrial and ventricular chambers 
of the Georgia Tech Left Heart Simulator (GTLHS). A laser-cut polyethylene 
terephthalate-glycol (PETG) plate is sealed against the acrylic base, providing 
support for the flexible neoprene skirt, which is sutured to the PETG plate. A stainless 
steel wire is imbedded within the neoprene skirt and cuff. 
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Figure 4-3 – Adjustable annulus plate design and function. An en face view of the MV 
from the atrium shows the operation of the adjustable annulus plate. Applying 
tension to a stainless-steel wire (green line) embedded in the annulus allows for 
adjustment of the annular size. A 1 cm calibration strip on the plate allows for 
measurement of the annular size on digital images (red annular outlines). 
A rigid acrylic plate was cut to fit between the atrium and ventricle of the GTLHS 
chamber. A pocket was machined into the plate such that the adjustable annulus assembly 
could be mounted within the rigid plate and vertical holes were drilled through the acrylic 
plate at the trigones. Finally, the stainless-steel wires were fed through those vertical holes, 
and the adjustable annulus assembly was sealed to the acrylic plate with silicone, 
completing assembly of the adjustable annulus. A 1 cm length plastic strip was affixed to 
the assembly on the atrial side just below the annulus. By taking an en face digital image 
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of the annulus and calibrating pixel length to the 1 cm strip, the MAA could be precisely 
measured on the digital images (Figure 4-3, APPENDIX B.1). 
4.1.4 Mitral Valve Selection and Preparation 
Ovine hearts of approximately 1 lb in total weight were sourced from an abattoir 
(Superior Farms, Dixon, CA, USA). The left atrium was trimmed from the heart, allowing 
visualization of the MV. A size 26 Edwards Physio annuloplasty ring sizer was used to 
confirm that the inter-trigonal distance of the MV sample matched the geometry of the 
annulus plate. After confirmation, an incision was made through the aorta and through the 
anterior aspect of the LV, between the PMs. Care was taken to preserve the chordae and 
PMs as the LV was cut open. Next, a medial cut was made to separate the right heart, and 
the excess tissue on the apex of the heart was removed. Two cuts were then made to 
separate the PMs from the annulus, then from each-other. The annular myocardium was 
then trimmed, leaving ~3-5 mm of myocardium above the color-change line of the annular 
hinge (Figure 4-4). 
Next, the annulus was sutured to the adjustable annulus plate. An initial single 
mattress suture was placed at the center of the anterior annulus, and matched to this location 
on the annulus plate. Three more mattress sutures were then placed at each trigone and at 
the center of the posterior annulus in the same way. Finally, a Ford interlocking stitch was 
started at the right trigone, and, placing each stitch 2-4 mm apart following the entire 
annular circumference, the annulus was sutured to the plate (Figure 4-4).  
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Figure 4-4 – MV excision and mounting. An incision is first made through the aorta 
and the anterior wall of the LV, revealing the MV (A).  Cuts are then made along the 
red lines to separate the myocardium, atrium and right ventricle from the MV, 
separate the PMs from the annulus, and separate the PMs from each other (A). Care 
is taken to preserve the leaflets, chordae, annulus and PMs. The annulus is sutured to 
the annulus plate of the GTLHS using a ford interlocking stitch (B). 
Cotton jersey knit (T-Shirt) fabric was used to create pouches encapsulating the PMs. 
A square of fabric was cut out and sized to the PM size. The fabric was wrapped around 
the PM long-ways from the chordal insertions to the back of the PM, leaving the sides 
open. Two running sutures starting from the base of the PM near the chordae were used 
suture the fabric together at either side of the PM (Figure 4-5). Further information on MV 
excision, MV mounting, and GTLHS setup and operation can be found in previous 




Figure 4-5 – Papillary muscle (PM) preparation. Cotton jersey knit (T-Shirt) fabric 
was used to create pouched encapsulating the PMs (A). After folding a rectangular 
section of the fabric long ways over the PM, two ford interlocking-stitches running 
up either side of the PM secures the fabric to the PM. Next, the plastic PM attachment 
is sutured to the PM. The fully mounted and prepped MV is shown in (B). 
4.2 Anterior Leaflet Tethering 
4.2.1 Papillary Muscle Displacement 
In FMR, LV dilatation causes PM displacement.4 This can cause leaflet tethering 
at a range of severities.47 This range was targeted for this study, in order to understand the 
effect of simulated MitraClip on forward flow obstruction in the setting of varying degrees 
of leaflet tethering, ranging from mild to severe. To achieve this effect in vitro, PMs were 
displaced laterally and posteriorly by adjusting the PM control rods on the exterior of the 
GTLHS, tethering the anterior mitral leaflet (AML) at three levels. AML tethering severity 
was assessed by the angle of the AML with respect to the annular plane, and is referred to 
as AML tether angle. The GTLHS adjustable annulus plate featured a planar annulus, 
allowing non-ambiguous definition of the annular plane and AML tether angle. AML tether 
angles of 75° (mild), 60° (moderate), and severe (45°) were replicated in this experiment. 
These levels were based on published human data quantifying AML tethering severity in 
FMR patients (Figure 4-6).47  
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Figure 4-6 – Mild, moderate and severe anterior mitral leaflet (AML) tether angle. 
AML tether angle was defined as the excursion angle of the AML from the mitral 
annular plane. (AML tethering diagrams modified from Otsuji et al47) 
4.2.2 Anterior Leaflet Angle Measurement 
PMs were displaced laterally and posteriorly in a symmetric manner, and AML tether angle 
was measured using 3D echo. PM displacement was empirically adjusted until reaching 
each target angle, as confirmed by 3D echo. Using the Philips 3DQ Measurement tools, a 
plane was positioned to bisect the MV on the A2/P2 plane (mid-point of the 
anterior/posterior leaflet) in peak diastole. Next the distance measurement tool was used to 
measure the three sides of a triangle, with the sides corresponding to the annular width, 
AML length and span from the anterior leaflet tip to the posterior annulus. The angle 
between the annular plane and the AML, θ, was calculated using Equation 1, where 𝐿𝐿𝐴𝐴𝐴𝐴𝐴𝐴 
is the length of the AML, 𝐿𝐿𝐴𝐴𝐴𝐴𝐴𝐴 is the distance from A2 to P2, and 𝐿𝐿𝑆𝑆𝑆𝑆𝑆𝑆𝐴𝐴 is the distance 
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Figure 4-7 – Measurement of AML tether angle using 3D echocardiography. For each 
anterior mitral leaflet (AML) tether angle, the distance from the annulus to the AML 
leaflet tip, 𝑳𝑳𝑨𝑨𝑨𝑨𝑳𝑳, was measured, followed by the width of the annulus, 𝑳𝑳𝑨𝑨𝒏𝒏𝒏𝒏, and the 
span between the posterior annulus and the AML leaflet tip, 𝑳𝑳𝑺𝑺𝑺𝑺𝑺𝑺𝒏𝒏. The angle of the 
AML with respect to the annular plane was then calculated using Equation 1. PML – 
Posterior mitral leaflet. 
4.2.3 Anterior Leaflet Angle Repeatability and Accuracy 
Once a target angle was reached, location of the PM rods on the exterior of the 
GTLHS was recorded. The recorded markings were used to precisely re-create the AML 
tether angles in the second phase of each experiment, where MitraClip placement was 
simulated with custom edge-to-edge clips (described in section 4.3). Additionally, to secure 
the PMs in their specific locations corresponding to each AML tether angle, cable ties were 
secured around the PM rods on the exterior of the GTLHS for each target angle, pulling 
the PM rods medially and hoisting them anteriorly (Figure 4-8). Different cable tie loops 
were made for each target angle, and could be easily swapped in and out. These were used, 
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in addition to the markings, to precisely re-create the desired target AML tether angles 
when MitraClip was simulated. 
To test the precision of PM positioning, a feasibility study was done on a single 
MV sample. PM positions were first determined for the target angles, and the PM positions 
were recorded for each AML tether angle. Next, the positioning methods described above 
were used to cycle through the progression of mild (75°), moderate (60°) and severe (45°) 
AML tether angles five times. For each angle and each cycle iteration, the AML tether 
angle was measured with 3D echo, allowing the precision and accuracy of the method to 
be quantified over a simulated experiment. 
 
Figure 4-8 – Papillary muscle (PM) tethering method. PMs were displaced posteriorly 
and laterally to create anterior mitral leaflet (AML) tethering (blue arrows, A). PM 
control rods on the exterior of the GT left heart simulator (GTLHS) were pulled 
medially and hoisted anteriorly (yellow arrows, A). Cable tie loops were secured to 
the PM control rods on the exterior of the GTLHS to affix the PMs in their displaced 
positions (B). These cable tie loops could be swapped easily, to re-create the different 




4.3 Custom GT Edge-to-Edge Clip Design, Fabrication and Use 
4.3.1 Design Constraints and Functions 
Prototype Georgia Tech edge-to-edge clips (GTclips) were designed to replicate 
the bite profile and dimensions of the MitraClip device (Figure 4-9). The MitraClip bite 
profile was obtained from the MitraClip IFU and is approximately 5 mm wide and 9 mm 
in length, with an overall device length of approximately 15 mm. The GTclips were 
machined from tough polycarbonate plastic and stainless steel. A cross-hatch pattern was 
etched into the gripping face of the clip to prevent clip detachment. 
4.3.2 Concept and Engineering Drawings 
These GTclips functioned in a similar manner to alligator clips, which allowed them 
to be quickly deployed and re-positioned without damaging the leaflets (Figure 4-9B). 
4.3.3 Materials Selection 
Due to the small size of features in the GTclip design, polycarbonate (PC) was 
selected for its high IZOD impact strength, and high elongation at break. Acrylic is another 
plastic commonly used in CFM lab applications, but small features tend to crack and 
fracture easily when fabricated from acrylic. The low specific gravity of PC compared to 
metals and steels is also desirable, to bring the GTclip close to neutral buoyancy. The spring 
elements at the back of the GTclip were made from 0.008” thick spring-tempered 301 
stainless steel strip sourced from McMaster-Carr (part no. 2416K42). The spring-temper is 
critical, so that the spring element does not plastically deform when opening the clip, and 
fail to provide closing force to the clip. 
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Figure 4-9 – Custom edge-to-edge (GTclip) design. Device dimensions from the 
MitraClip IFU are shown in (A). Dimensions and computer aided design (CAD) of 
the GTclip are shown in (B).  
4.3.4 Fabrication and Assembly 
The PC grippers were CNC machined from a single PC sheet. The CNC tool paths 
were generated with HSMworks in SolidWorks (Dassault Systemes, Waltham, MA, USA) 
(Figure 4-10A,B). Engineering drawings are shown in APPENDIX B.2. Following 
machining, the parts were de-burred and a gripping pattern was cut into the gripping face 
of the parts by hand using a razor blade (Figure 4-10C,D). Next, a stainless-steel pin was 
placed in the actuating joint to hold two grippers together. A 2-0 black silk suture was used 
to tie the two grippers together. Finally, a rotary tool was used to cut out the spring steel 
elements. These were bent into shape using needle nose pliers and secured between the two 
grippers at the back of the GTclip (Figure 4-10E,F).  
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Figure 4-10 – Custom edge-to-edge clip (GTclip) fabrication and assembly. Tool paths 
for CNC machining were designed in HSMworks for SolidWorks, and the GTclip 
grippers were machined from a single sheet of polycarbonate (A,B). The grippers 
were de-burred and a gripping pattern was cut into the gripping face with a razor 
blade (C,D). The spring element was cut from a spring tempered 0.008” thick 301 
stainless steel strip using a rotary tool. The spring element is dimensioned as shown 




4.3.5 GTclip Implantation 
GTclip was quickly and easily installed on MV samples for this experiment (Figure 
4-11A). Minimal echo attenuation and noise was observed from the mostly-plastic design 
(Figure 4-11 B-D). Over the course of data collection, no instances of clip detachment or 
leaflet damage were observed. In order to understand how placement of one or two 
MitraClip devices in common locations on the MV affects forward flow obstruction in the  
setting of AML tethering, four common implantation positions44, 46, 53 were selected for this 
experiment (Figure 4-12). The single central clip placement is the standard placement of 
MitraClip for central MR.15, 43 If significant MR persists following implantation of a single 
central clip, another clip may be deployed next to the first, creating the double central clip 
placement.54 In cases of non-central MR, placement of the device in the commissure is 
commonly performed.55 When MR persists, an additional clip may be deployed more 
centrally, creating the central and commissural clip placement.55 These four strategies were 
replicated with GTclip for each MV sample in the experiment (Figure 4-12). 
4.3.6 GTclip Bite Profile Verification 
Following central implantation of GTclip in a feasibility trial, the geometry of the 
approximated AML and PML was compared to that of a MitraClip patient. The width of 
the bite profile for GTclip was measured with both 3D echo and with en face 
photogrammetry. This was compared to the width of the MitraClip leaflet bite profile in a 




Figure 4-11 – GTclip placement. Central clip placement on an excised ovine MV 
sample is shown in (A). In 3D echo, the device can be seen in position (B,C). A 2D 
planimetry tracing of one orifice is shown (D). PM – Papillary Muscle; AML – 
Anterior Mitral Leaflet; PML – Posterior Mitral Leaflet. 
 
Figure 4-12 – Simulated GTclip positions. In addition to control conditions without 
GTclip (left), two single-GTclip placements and two double-GTclip placements were 
simulated. These mimic commonly used single and double MitraClip placements. 
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4.4 Experimental Protocol and Conditions 
4.4.1 Experimental Conditions and Matrix 
The experimental matrix of conditions is shown in (Table 4-1). The mitral annular 
area (MAA) was adjusted for each MV sample, and ranged from 3.6 to 4.8 cm2. The MAA 
was not varied during the course of an experiment, but was varied between experiments. 
Each of the three AML tether angles was simulated before GTclip implantation, and for 
each of the four GTclip placements, yielding fifteen different conditions for each 
experiment.  
4.4.2 Experimental Protocol 
For each experiment, PM positions were first determined for each AL tethering 
angle with no clips implanted, and corresponding retainers were adjusted for each angle. 
Once each desired AL tether angle was reached, pressure and flow waveforms were 
recorded along with 3D gated echo images. Next, the commissural clip placement was 
simulated, and the three AL tether angles were sequentially re-created using the set of 
retainers. Pressure and flow waveforms, and 3D gated echo were recorded at each AL tether 
angle. These steps were repeated for each subsequent clip placement strategy (single 





Table 4-1 – Experimental matrix of conditions. Test conditions simulated on each MV 
sample for the experiment. 
 
4.5 Experimental Measurements 
4.5.1 MV Pressure Gradient 
Mean and peak MV gradients (MVG) were measured during the diastolic phase of 
the cycle using the pressure transducer recordings. The difference between instantaneous 
atrial and ventricular pressure was computed, then the mean of the gradient was computed 
for the diastolic phase of the cycle using MATLAB R2016B (MathWorks, Natick, MA, 
USA). The maximum magnitude of the diastolic gradient was recorded for peak MVG 
value. The change in mean/peak MVG from pre-clip to post-clip was also computed for 
each GTclip position. 
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4.5.2 MV Area 
Peak diastolic MVA was manually measured by planimetry on the 3D Echo images 
using Philips QLab 9.0 3DQ software (Philips North America, Andover, MA, USA), and 
the change in MVA from pre-clip to post-clip was computed. MVA was measured 
following established echocardiographic technique56; an orthogonal plane was placed 
perpendicularly to the valve leaflets at peak diastole, and the orifice was carefully traced 
within the measurement plane. In the case of multiple orifices, planes were independently 
placed to measure each orifice, then summed for total MVA (Figure 4-11D). Measurements 
on each image were made three separate and independent times, and the intraclass 
correlation coefficient with 95% Confidence Interval (95%CI) was found to be 0.983 
(0.977-0.989), indicating that measures were reliable. 
4.5.3 Fluid Forces on the MV Apparatus 
Ideally, the AML will impose minimal resistance to the fluid flowing from the LA 
to the LV in diastole. Increased resistance to forward flow due to AML tethering and 
GTclip placement indicates that the fluid is imparting a greater force on the MV apparatus. 
Estimating the change in fluid force caused by GTclip and AML tethering may shed light 
on the mechanics of forward flow obstruction and redirection. Here, fluid flow through a 
narrowing pipe bend was assumed as a simplified model of the effect of the tethered MV 
on the diastolic filling flow (Figure 4-13).57  
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Figure 4-13 – Reaction force on the tethered anterior mitral leaflet (AML). Fluid flow 
through the MV in diastole can be modeled as a pipe-bend. A cross section of the MV 
under severe tethering is shown in (A), where the AML, left atrium (LA), and left 
ventricle (LV) are shown. The control volume analysis is shown in (B). 
Reducing the governing equation describing conservation of momentum, reaction 
force of the valve on the inflow jet is described by Equations 2 and 3 below, for force in 
the x-direction, 𝑅𝑅𝑥𝑥, and in the y-direction, 𝑅𝑅𝑦𝑦, respectively. Here, 𝛽𝛽 is the angle of the AML 
to the horizontal (90°-AML angle). 𝐴𝐴1 and 𝑝𝑝1 represent the annular area and peak diastolic 
atrial pressure, respectively, while 𝐴𝐴2 and 𝑝𝑝2 represent the peak diastolic MVA and 
ventricular pressure, respectively. Finally, 𝑄𝑄 is the peak instantaneous flow rate through 
the valve in diastole. 
 











+𝐴𝐴2𝑝𝑝2)𝑐𝑐𝑠𝑠𝑠𝑠 𝛽𝛽 (3) 
The drag force (N) of the inflow jet on the MV apparatus in the direction of the 
inflow jet is represented by 𝑅𝑅𝑥𝑥. Total fluid force (N) on the MV apparatus was determined 
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by calculating the magnitude of the force vector by Equations 2 and 3. These metrics were 
calculated for each experiment, and each condition. 
4.6 Statistical Analysis and Modeling 
All statistical tests and modeling was conducted using Minitab 18 statistical software 
(Minitab Inc, State College, PA, USA). Additionally, unless stated otherwise, all results 
are presented as mean ± 95% confidence interval. 
4.6.1 General Linear Model: Independent Variables, Covariates, and Dependent 
Variables 
Within the experimental model, AML tether angle and GTclip configuration were 
treated as independent categorical variables. The MAA for each valve was introduced as a 
continuous covariate variable. These make up the three independent variables controlled 
in this study. The dependent variables were MAA, mean MVG, peak MVG, total fluid 
force, and drag force. A general linear model (GLM) was fitted to the data for five separate 
analyses on the resulting MVA, mean MVG, peak MVG, total fluid force, and drag force. 
Additionally, a GLM was fitted to the post-clip increase mean and peak MVG over baseline 
without GTclip, and the decrease in post-clip MVA below baseline without clip. The model 
fit for each group is described by Equation 4,  
 𝑦𝑦 = 𝑘𝑘 + (𝑀𝑀𝐴𝐴𝐴𝐴)𝛼𝛼 + 𝛽𝛽 + 𝛾𝛾 + 𝜀𝜀 (4) 
Error! Bookmark not defined.where 𝑦𝑦 is the dependent variable, ie. estimated 
MVA/MVG measurement. The coefficients on the right-hand side of the equation are 
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statistically calculated by the minitab GLM to best fit the changes observed in the 
dependent variable. The first term on the right side, 𝑘𝑘,  is a constant offset coefficient. The 
second term is adding the effect of the continuous variable, MAA, which is directly 
multiplied by its slope coefficient, 𝛼𝛼, to give the contribution of MAA to the magnitude of 
the dependent variable. Next, a coefficient for GTclip placement, 𝛽𝛽, and for AML tether 
angle, 𝛾𝛾, is added. Because these two variables are categorical, their coefficients are 
produced in a lookup table. For example, to calculate the estimated MVA after placement 
of a single central GTclip with a moderate AML tether angle, the coefficients for these two 
categories would be selected and inserted into Equation 4 for 𝛽𝛽 and 𝛾𝛾, respectively. Finally, 
an error term, 𝜀𝜀, describes the model error. 
These coefficients and overall statistical significance were computed for each factor 
and level using the Minitab GLM tool. Percent contribution to total sum of square variance 
was computed for AML tether angle, GTclip configuration, and baseline MAA. This 
contribution percentage represents the portion of variance in the dependent variables that 
can be attributed to each independent variable. In other words, this is the relative size of 
the effect that GTclip placement, AML tether angle, and MAA have on the decrease in 
MVA and increase in MVG. 
4.6.2 Normality of Results and Equality of Variance 
Bartlett’s test and residual analysis was performed on all dependent variables. This 
is a test of the null hypothesis that observations come from normal distributions with the 
same variance. In all cases, the data was determined to be normally distributed with equal 
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variance. Thus, assumptions underpinning the GLM were not violated, and the model 
results were valid. 
4.6.3 Post-Hoc Test 
Using the “Comparison” tool in Minitab 18, multiple comparison via Tukey’s HSD 
procedure was conducted on the mean measurements of each group, to test differences in 
groups per the main effects of AML tether angle, GTclip configuration, and MAA. This 
provides the mean measurement (MVA, mean MVG, peak MVG, Total Fluid Force or 
Drag Force) and 95%CI for each combination of GTclip and AML tether angle at the mean 
MAA, allowing significant differences between groups to be detected. 
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CHAPTER 5: RESULTS 
This section is arranged as follows. First, verification data on the GTclip bite profile 
and anterior mitral leaflet (AML) tether angle repeatability are presented. Next, the 
coefficients of the general linear models are presented, along with analysis of the effect of 
mitral annular area (MAA) on mean MV gradient (MVG), peak MVG, and MV area 
(MVA). This is followed by analysis of average values for mean/peak MVG and MVA at 
the mean MAA of 4.15 cm2. Next, an analysis on the incidence of moderate mitral stenosis 
(MS) as a function of GTclip placement and AML tether angle is presented. Following the 
analysis of MS descriptors, mechanistic insights into forward flow obstruction are 
presented with the analysis of total fluid force and drag force on the MV apparatus at peak 
diastole. Finally, average baseline and post-clip values form this experiment are compared 
with those from clinical reports. 
5.1 GTclip Bite Profile Verification 
The leaflet bite profile of GTclip compared favorably to that of central MitraClip 
implantation in a patient. GTclip had a width of 5 mm, which created a bite with of 
approximately 6.5 mm, as measured in 3D echo and photogrammetry. In comparison, the 
width of MitraClip is 5 mm, and a leaflet bite width of approximately 6.8 mm was observed 
in a MitraClip patient. Furthermore, engineering studies have commonly simulated 
MitraClip by reproducing the leaflet bite profile of the device.33, 58 
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Figure 5-1 – Custom edge-to-edge clip (GTclip) leaflet bite profile verification. GTclip 
had a width of 5 mm, which created a bite with of approximately 6.5 mm, as measured 
in 3D echo and photogrammetry (A,B). In comparison, the width of MitraClip is 5 
mm, and a leaflet bite width of approximately 6.8 mm was observed in a MitraClip 
patient (C). The dimensions of GTclip match those of MitraClip (D). 
5.2 Leaflet Tethering Repeatability 
Results in this section are reported as mean ± standard deviation. The AML tether 
angle repeatability experiment demonstrated that the applied methods created AML tether 
angles of 76.5±2.3°, 59.5±2.8°, and 47.6±2.0°. Subsequently, the tether angles achieved 
over the course of data collection were 75.2±2.3°, 60.7±2.1°, and 45.1±1.8°. The published 
human data47, the results of the repeatability testing, and the mean AML tether angles 
observed during data collection are shown in Figure 5-2. 
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Figure 5-2 – Results of anterior mitral leaflet (AML) tethering repeatability test 
compared with published human data. Repeatability testing showed the AML 
tethering method reliably reproduced the desired condition, and AML tether angle 
results over the course of the study showed that the reliability was preserved. (AML 
tethering diagrams modified from Otsuji et al47) 
5.3 Factors Impacting Mitral Valve Area and Gradients 
Results showed that AML tether angle, GTclip placement, and baseline annular area were 
significant factors impacting the measured mean MVG, peak MVG, and resulting MVA 
(p<0.001 for each factor and measurement). Factor significance, factor contributions and 
model coefficients are tabulated in  
Table 5-1. Coefficients can be used to calculate mean and 95%CI values for the 
measurements. An example MVA calculation is shown in Equation 1, 
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 𝑀𝑀𝑀𝑀𝐴𝐴 = 𝑘𝑘 + (𝑀𝑀𝐴𝐴𝐴𝐴 − 4.0)𝛼𝛼 + 𝛽𝛽 + 𝛾𝛾 (5) 
 where the constant coefficient, 𝑘𝑘, is summed with the GTclip coefficient, 𝛽𝛽, for the 
desired clip placement, and the AML coefficient,  𝛾𝛾, for the desired AML angle. Finally, 
the product of MAA and the MAA coefficient,  𝛼𝛼, are added as shown to produce the MVA 
estimate given the selected inputs. 
5.4 Effect of Baseline Mitral Annular Area 
No significant post-procedural mean MVG (mean MVG >5mmHg) was observed 
in the two samples with baseline MAA≥4.4cm2. In contrast, 13 incidents of mean 
MVG>5mmHg were observed in the samples with baseline MAA<4.1cm2 (60 total 
experiments, frequency of 22%). Calculated based on the coefficient results shown in Table 
5-1, the smallest MAA that resulted in mean MVG under 5mmHg was 4.7 cm2, even in the 
presence of severe AML tethering and implantation of two GTclips. In other words, the 
mean MVG at baseline MAA of 4.7 cm2, with severe AML tethering, and with central and 
commissural GTclips placed was 4.3±0.6 mmHg. Baseline MAA of 4.7cm2 with severe 






Table 5-1 – Coefficients and contributions of factors affecting MV gradient (MVG) 
and area (MVA). All three factors, AML tether angle, GTclip placement, and baseline 
Mitral Annular Area (MAA), were found to significantly affect the three resulting 
measurements (mean MV gradient, peak MV gradient, and MV area), p>0.001 for 
all. The percent contributions show the relative importance of the effect of each factor 
on the measurement (contribution to total sum of square variance). Contribution of 
statistical error and small interaction contributions are not shown. Coefficient units 
are those of the corresponding measurement. 
Main Factor / Term Contribution Coefficient 95% CI P-Value 
Mean MVG (mmHg)        (R2=0.83) 
 Constant (𝒌𝒌)  3.81 (3.71, 3.91) <0.001 
    𝑨𝑨𝑨𝑨𝑨𝑨 − 𝟒𝟒.𝟎𝟎 𝒄𝒄𝒄𝒄𝟐𝟐 (𝜶𝜶) 28.24% -1.55 (-1.80, -1.30) <0.001 
    GTclip Placement   (𝜷𝜷) 39.06%   <0.001 
 None  -0.99 (-1.19, -0.80) <0.001 
 Single Comm.  -0.43 (-0.61, -0.24) <0.001 
 Single Central  0.01 (-0.17, 0.20) 0.887 
 Dual Central  0.54 (0.37, 0.73) <0.001 
 Central+Comm.  0.86 (0.68, 1.05) <0.001 
    AML Tether Angle    (𝜸𝜸) 16.04%   <0.001 
 75 degrees  -0.33 (-0.47, -0.20) <0.001 
 60 degrees  -0.24 (-0.37, -0.11) 0.001 
 45 degrees  0.57 (0.44, 0.70) <0.001 
Peak MVG (mmHg)          (R2=0.75) 
 Constant (𝒌𝒌)  6.91 (6.70, 7.12) <0.001 
    𝑨𝑨𝑨𝑨𝑨𝑨 − 𝟒𝟒.𝟎𝟎 𝒄𝒄𝒄𝒄𝟐𝟐 (𝜶𝜶) 24.37% -2.44 (-2.97, -1.90) <0.001 
    GTclip Placement   (𝜷𝜷) 36.13%   <0.001 
 None  -1.50 (-1.92, -1.09) <0.001 
 Single Comm.  -0.78 (-1.18, -0.38) <0.001 
 Single Central  -0.10 (-0.50, 0.30) 0.627 
 Dual Central  0.78 (0.38, 1.17) <0.001 
 Central+Comm.  1.61 (1.21, 2.01) <0.001 
    AML Tether Angle     (𝜸𝜸) 14.04%   <0.001 
 75 degrees  -0.54 (-0.82, -0.25) <0.001 
 60 degrees  -0.40 (-0.69, -0.12) 0.006 
 45 degrees  0.94 (0.66, 1.22) <0.001 
MVA (cm2)                         (R2=0.95) 
 Constant (𝒌𝒌)  2.21 (2.16, 2.26) <0.001 
    𝑨𝑨𝑨𝑨𝑨𝑨 − 𝟒𝟒.𝟎𝟎 𝒄𝒄𝒄𝒄𝟐𝟐 (𝜶𝜶) 7.04% 0.65 (0.53, 0.78) <0.001 
    GTclip Placement   (𝜷𝜷) 80.65%   <0.001 
 None  1.53 (1.44, 1.62) <0.001 
 Single Comm.  -0.04 (-0.13, 0.05) 0.402 
 Single Central  -0.13 (-0.22, -0.03) 0.009 
 Dual Central  -0.49 (-0.59, -0.40) <0.001 
 Central+Comm.  -0.87 (-0.97, -0.78) <0.001 
    AML Tether Angle    (𝜸𝜸) 6.85%   <0.001 
 75 degrees  0.25 (0.18, 0.32) <0.001 
 60 degrees  0.07 (0.01, 0.14) 0.034 
 45 degrees  -0.32 (-0.39, -0.26) <0.001 
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Figure 5-3 – Effect of baseline mitral annular area (MAA) on mitral stenosis with 
severe anterior mitral leaflet (AML) tethering, and placement of central and 
commissural GTclips. With conditions of severe AML tethering, and placement of 
central and commissural GTclips, mean and peak MVG values were estimated using 
the coefficients in Table 5-1. 
5.5 Mitral Valve Area and Gradient at the Mean Mitral Annular Area  
The mean MAA of all experiments was 4.15 cm2. At this MAA, resulting MVA and 
MVG values (mean±95%CI) for all combinations of AML tether angle and GTclip 
placement are shown in Figure 5-4. Groups whose 95%CIs do not overlap are significantly 
different (p<0.05). The p-values for each possible comparison are tabulated in Tables A-
3, A-4, and A-5 of the Appendix A. In the case of mild AML tethering without clipping, 
the mean MVG was found to be 2.4±0.4 mmHg, while the mean MVA was 4.0±0.2 cm2. 
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The severe AML tether angle alone caused an insignificant increase in mean MVG to 
3.0±0.4 mmHg (p=0.49), but a significant decrease in MVA to 3.6±0.2 cm2 (p<0.05). With 
commissural and central clips placed in the setting of a severe AML tether angle, the mean 
MVG was observed to be significantly greater at 5.7±0.6 mmHg (p<0.001), and four of six 
samples were moderately stenotic (mean MVG>5.0 mmHg). MVA in this case was found 
to be significantly smaller at 1.2±0.2 cm2 (p<0.001). No significant differences were 
detected between the mild (75°) and moderate (60°) AML tether angles within each GTclip 
placement group, but larger-magnitude changes were observed in the severe (45°) group. 
5.6 Change in Mitral Valve Area and Gradient from Baseline 
Baseline MVA and MVG decreased and increased, respectively, as a function of 
AML tether severity. Taking the pre-clip results as a baseline, the elevation in MVG and 
decrease of MVA are shown for each clipped condition in Figure 5-4 (orange bars). AML 
tether angle was found to be a significant factor, but only in the mean and peak MVG, 
indicating that the increase in MVG from baseline to post-clip is significantly larger in the 





Figure 5-4 – Mean MV gradient (MVG), peak MVG, and MV area by GTclip 
placement and anterior mitral leaflet (AML) tether angle. Absolute mean and 95% 
confidence interval (95%CI) are shown via the grey bars for each group at a baseline 
annular area of 4.15 cm2. Mean difference from pre-clip baseline with 95%CI is 
shown via the orange bars.  The cutoff values for moderate MS are denoted by the 
red dotted lines. Statistically significant differences can be observed between groups 
whose 95%CIs do not overlap. A full table of p-values can be found in the Appendix 
A, Tables A-3, A-4 and A-5. 
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Figure 5-5 – Change from pre-clip baseline in mean MV gradient (MVG), peak MVG, 
and MV area (MVA) by anterior mitral leaflet (AML) tether angle. Mean values with 
95% confidence interval (95%CI) computed at a baseline annular area of 4.15 cm2. 
The effect of AL tether angle was significant for the rise both mean and peak MVG 
(p<0.05), but was not significant for the drop in MVA (p=0.086). * p<0.05 
5.7 Rates of Mitral Stenosis by GTclip Placement and Anterior Mitral Leaflet 
Tether Angle 
Across all experimental conditions, moderate MS (mean MVG>5mmHg) was 
created in 13 cases, 11 of which were found in the setting of severe AML tethering. 
Combined, mild and moderate AML tethering created MS at a frequency of 4%, while the 
frequency of MS for severe AML tethering was 46%.  Clinical reports suggest avoiding 
placement of additional MitraClip if mean MVG is observed to be >4 mmHg.44 Among all 
single-GTclip experiments, this threshold was exceeded only once (frequency of 8%) for 
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each of 75° and 60° AML angles, but five times (frequency of 42%) with severe AML 
tethering (Figure 5-6). 
         
Figure 5-6 – Rates of moderate stenosis (MS) by GTclip placement and anterior 
mitral leaflet (AML) tether angle. Incidence of mean MVG≥4 mmHg (placement of 
additional GTclip not advised) and mean MVG≥5 mmHg (moderate MS) are shown 
in the grey bars and red bars, respectively. Total sample size was N=6 per condition. 
5.8 Fluid Forces on the Mitral Valve Apparatus 
The mean MAA of all experiments was 4.15 cm2. At this MAA, resulting total fluid 
force and drag force values (mean±95%CI) for all combinations of AML tether angle and 
GTclip placement are shown in Figure 5-7. Groups whose 95%CIs do not overlap are 
significantly different (p<0.05). In the case of mild AML tethering without clipping, the 
drag force was found to be 0.37±0.06 N, while the total fluid force was 0.47±0.05 N. The 
severe AML tether angle alone caused a significant increase in drag force to 0.77±0.06 N 
(p<0.001), and a significant increase in total fluid force to 1.03±0.05 N (p<0.001). Without 
clipping, the total fluid force was found to be significantly greater than the drag force, in 
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the case of moderate and severe AML tethering (p>0.05 for both). However, after clipping, 
the fluid force and drag force were not significantly different, indicating that the force on 
the MV apparatus was dominated by drag after clipping (p>0.05 for all). In the most severe 
obstruction (commissural and central clips placed in the setting of a severe AML tether 
angle), the drag force was observed to 1.37±0.06 N, and the total fluid force was found to 
be 1.40±0.05 N. Both were significantly greater than their pre-clip counterparts (p<0.001 
for both. In contrast to the MVA and MVG findings, significant differences in force were 
often observed between the mild and moderate tether angles. A full list of results, and p-
values for each possible comparison are tabulated in Tables A-6 and A-7 of Appendix A. 
 
Figure 5-7 – Drag force and total fluid force on the MV apparatus by GTclip 
placement and anterior mitral leaflet (AML) tether angle. All values displayed as 
mean± 95% Confidence Interval (95%CI). Statistically significant differences can be 
observed between groups whose 95%CIs do not overlap. A full table of p-values can 
be found in Appendix A, tables A-6 and A-7. 
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5.9 MitraClip Clinical Comparison  
In 12 FMR patients with varying degrees of leaflet tethering, Chan et al 48 report a 
baseline mean±95%CI MVA and mean MVG of 3.60±0.38 cm2 and 2.20±0.83 mmHg, 
respectively. In the same study, after implantation of 1.3±0.7 MitraClip per patient, follow-
up MVA and mean MVG were found to be 1.50±0.25 cm2 and 4.90±1.02 mmHg, 
respectively. Averaged across AML tether angles, baseline MVA and mean MVG were 
found to be 3.83±0.32 cm2 and 2.70±1.13 mmHg, respectively. Following placement of 
1.5±0.5 GTclips, MVA and mean MVG values were found to be 1.92±0.46 cm2 and 
3.83±1.03 mmHg, respectively. Averaged across AML angle severity and GTclip 
placement, these results were not significantly different from a cohort of 12 patients with 
FMR (p>0.05 for all).48 This indicates that the in vitro model presented herein was able to 
faithfully reproduce baseline and post-clip hemodynamics (Figure 5-8A,B). 
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Figure 5-8 – Comparison of MV area (MVA) results and mean MV gradient (MVG) 
results to clinical data. Mean ± 95% Confidence Interval MVA and MVG are shown 
for a cohort of 12 FMR patients both pre- and post-clip.48 No significant differences 
were detected. NS - p>0.05  
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CHAPTER 6: DISCUSSION 
A clinically recognized suboptimal outcome of MitraClip treatment is the undesired 
creation of MS.16, 25, 40, 41 A recently published report by Neuss et al has shown that 
significantly poorer long-term patient outcomes result with post-procedural mean MVG≥5 
mmHg.40, 42 Though undesired creation of MS may be a consequence of MitraClip therapy, 
well-established guidelines and practices are currently in-place to avoid such a result.40, 44 
Per the MitraClip IFU and EVEREST trials, MR patients with baseline MVA<4.0cm2 are 
contraindicated for MitraClip treatment.15 Per clinical practice, multiple MitraClip devices 
may be deployed to fully treat MR, but placement of additional devices may further reduce 
MVA and increase MVG. As a general guideline, additional clips are not placed if the 
patient has mean MVG≥4mmHg.44 
Clinical evidence has suggested that AML tethering commonly seen in FMR may 
have an impact on the level of MS resulting from MitraClip implantation,48 but studies on 
its effects are limited. To investigate this experimentally, MS severity after MitraClip in 
the setting of varied levels of AML tethering was quantified using an in vitro left heart 
model.28, 50, 59 AML tethering was a significant factor affecting resulting MVG and MVA, 
as well as the change in those measures from pre-clip baseline. 
6.1 Use of GTclip to Simulate MitraClip 
MitraClip was simulated by replicating the size of the arms of the device with a 
custom edge-to-edge clip (GTclip). Qualitatively, the GTclip successfully approximated 
the leaflets at the site of implantation, and no incidence of leaflet damage or GTclip 
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detachment was observed. More quantitatively, the width of the leaflet bite of GTclip under 
echo imaging was compared to that of MitraClip. In-use, GTclip was found to closely 
match this bite profile. Though the method of action was different, the spring loaded 
GTclip was able to approximate the mitral leaflets in a sufficiently similar manner to a fully 
closed MitraClip device. This method of MitraClip simulation has also been previously 
established in computational models. Instead of creating a fully functioning model of 
MitraClip, the effect is simulated by creating two rigid rectangular gripping surfaces with 
the same dimensions as the MitraClip grippers, and using those to approximate the 
leaflets.33, 58 This is analogous to the approach adopted in this work to simulate MitraClip 
implantation. 
6.2 Insights into the Effects of AML Tethering 
Within each GTclip group, no differences between AML tether angles of 75° and 
60° were observed. However, much larger effects were observed at the severe AML tether 
angle of 45°. In the presence of severe AML tethering, a higher rate of moderate MS was 
observed, as compared to that in the presence of mild or moderate AML tethering (46% 
versus 4%, respectively). However, baseline MVA was significantly lower and baseline 
MVG was trending higher in the presence of severe AML tethering, so the increase in 
MVG and decrease in MVA after GTclip placement was computed. Mean and peak MVG 
was found to increase by a significantly larger magnitude in the presence of severe AML 
tethering, indicating that the AML tether severity may be an important factor for which to 
account. 
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AML tethering was found to have the dual effect of narrowing the MV orifice, and 
redirecting flow. The larger jet redirection angle may be a factor causing these large effects 
only at the most severe tether angles. To explore this, the drag force and total fluid force 
on the AML was computed using the simplified analysis of fluid force on a narrowing pipe 
bend. Both total fluid force and drag force were found to be significantly larger with severe 
AML tethering than with normal or moderate AML tethering, under all simulated GTclip 
positions (p<0.05). The fluid force on the MV apparatus may be balanced by the annulus, 
or the PMs. Additionally, loading on the AML may be balanced by the PML and posterior 
annulus via the GTclip, suggesting that the tension applied to the GTclip in diastole is 
greater with severe AML tethering. These observations suggest that the AML is under more 
tension at the most severe tether angles, and could explain the larger increase in MVG and 
decrease in MVA caused by GTclip placement under this condition. 
6.3 Effect of GTclip Placement 
The resulting MS severity largely depended on GTclip number, but was also 
affected by the positioning of GTclips. For example, resultant MVA after commissural 
GTclip placement was not significantly different from that after central GTclip placement, 
but mean MVG was significantly higher after central GTclip placement than after 
commissural GTclip placement (p<0.05). This could be attributed to the greater resistance 
to flow in the double-orifice case, despite the total MVA being equal. Differences between 
the double-clip cases were also observed. In the case of a double central GTclip placement, 
two distinct orifices were made. Placement of commissural and central GTclips created a 
single larger orifice, a smaller orifice between the GTclips, and a small orifice in the 
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commissure, which caused mean MVG to trend higher than that in the double central 
GTclip placement. 
Clinical reports suggest avoiding placement of additional MitraClips if mean MVG 
is observed to be ≥4 mmHg.44 Among single-GTclip experiments, a higher rate of mean 
MVG≥4mmHg was observed in the severe AML tethering group than in the combined 
mild and moderate group (42% versus 8%, respectively). In these cases, a “compromise” 
must be made between further reduction of MR and increase in MVG caused by placing 
additional GTclips. A similar finding has been reported clinically, with higher rates of 
“compromise” in patients with more severe AML tethering.48 
The purpose of the 4 mmHg cutoff is to predict whether MS will be created after 
placement of an additional clip. However, the cutoff of 4 mmHg did not always accurately 
predict presence of MS after placement of additional GTclips. Some cases arose where 
placement of the second GTclip unexpectedly caused MS, along with some cases where 
this unexpectedly did not cause MS. First, commissural GTclip placement resulted in the 
lowest mean MVG, and an additional GTclip may often be permitted. However, mean 
MVG was highest in the central+commissural group. In four of 18 cases, mean MVG<4 
mmHg resulted after commissural GTclip placement, followed by mean MVG≥5mmHg 
after placement of the second central GTclip. This occurred at a rate of 17% for mild and 
moderate AML tethering, and 33% for severe AML tethering. Because of the larger 
increase in mean MVG observed with severe AML tethering, and the larger increase 
observed from single commissural to central and commissural GTclip placement, this 
scenario led to a higher likelihood of unexpected MS. 
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Conversely, central GTclip placement resulted in higher mean MVG, and 
placement of an additional GTclip often may not be permitted. However, mean MVG was 
lower after double central GTclip than after central+commissural GTclip. In two of 18 
cases, mean MVG≥4mmHg resulted after the first central GTclip, followed by mean 
MVG<5mmHg after the second central GTclip. Both were observed at AML excursion 
angles of 75° and 60°, respectively. Here, because of the smaller increase in mean MVG 
observed with mild and moderate AML tethering, and the smaller increase observed from 
single central to double central GTclip placement, the second GTclip did not cause MS, 
even though the cutoff was exceeded after the first GTclip. 
6.4 Drag Force and Total Fluid Force on the Mitral Valve 
Using control volume analysis and assuming the MV orifice to resemble an angled, 
narrowing pipe bend, the fluid force on the MV was calculated. In the case of the narrowing 
pipe bend, these forces correspond to the total thrust-block force, and the thrust block force 
in the direction of the inflow jet. In other words, the calculated force is the reaction force 
needed to keep the pipe bend (or MV) stationary. This in the case of the MV, this force 
must be balanced by the annulus and PMs, which are the two fixtures of the MV. The forces 
are made up of two components: the change in momentum of the flow from the inlet 
(annulus) to the outlet (past the leaflets), as well as the pressure force acting on the inlet 
control surface and the outlet control surface. 
Interestingly, the total fluid force on the MV was significantly larger than the drag 
force only in the baseline pre-clip case. This indicates that, before GTclip is applied, a more 
substantial “lift” force, or force orthogonal to the inflow, is generated by the tethered AML. 
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However, once GTclip is applied, the substantial reduction in outlet area causes the total 
calculated fluid force to be dominated by drag force. After applying a single central GTclip 
in the setting of severe AML tethering, total force increased from 1.03±0.05 N to just 
1.18±0.05 N. Drag force, however, increased from 0.77±0.06 N to 1.12±0.06 N. This could 
explain the larger contribution that GTclip has to the increase in forward flow obstruction, 
as compared to that of AML tethering. However, in combination, severe AML tethering 
and GTclip created clinically significant and larger magnitude forward flow obstruction. 
6.5 Impact of Area on Gradients and Area Measurement Challenges 
Several factors make MVA challenging to measure in MitraClip pre-procedural 
planning and evaluation: the three-dimensional MV orifice, the limited capacity for 
echocardiographic measurement of areas below 0.5cm2, and the lack of a single, gold-
standard measurement approach.56 Nevertheless, MVA by planimetry has been found 
clinically to correlate with resulting rates of MS better than other methods (Pressure Half-
Time MVA and 3D MVA by MVQ).56 Therefore, all MVA measurements in this study 
were made by established planimetric guidelines. 
The present in vitro investigation was limited by these same challenges.  However, 
the GTLHS offered precise control of annular area (MAA). Accordingly, within the 
limitations of this system and the range of tested GTclip configurations, the statistical 
model identified 4.7 cm2 as the MAA above which severe AML tethering did not cause 
Moderate MS (MVG≥5mmHg), even with placement of two GTclips (95% certainty). At 
this MAA, the model identified the mean baseline MVA to be 3.9±0.3cm2 (at 45°), showing 
that, while MS was more frequent with severe AML tethering, the established MVA cutoff 
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of 4.0cm2 was applicable for these findings. These results showed that MS occurred at the 
highest rate with severe AML tethering (45° diastolic excursion angle) and MVA<4.0cm2. 
6.6 Comparison to Existing Engineering Studies 
Many in vitro, computational, and in vivo studies have been conducted to understand 
the efficacy of the E2E repair and MitraClip under certain conditions, the loading on the 
repair over the cardiac cycle, and the stress patterns in the leaflet caused by the repair.26-29, 
31, 33, 34, 38 Nielsen and colleagues measured force on E2E transducer simulating the Alfieri 
stitch in healthy and acute IMR animals.31 They found a larger-magnitude force on the 
repair the diastolic phase of the cycle, indicating that the repair caused increased leaflet 
strain in diastole. However, the authors attributed this finding to the change in annular size 
over the cardiac cycle, and did not examine the force as a function of MVG. The current 
study calculated significantly higher force on the MV apparatus with severe AML 
tethering. This indicates that the tethered AML is under more strain in diastole, and may 
mean that more tension is being applied to the GTclip, than without tethering. Future 
studies are needed to directly measure the loading on the mitral leaflets as a function of 
MVG, and determine the implications for repair durability. 
The previously mentioned studies have well characterized loading on the E2E repair, 
but parametric analyses on the effect of MitraClip on forward flow obstruction is lacking. 
Many of these studies simulated E2E repair or MitraClip on valves with MVA>5.5 cm2; 
the data herein has shown that likelihood of elevated MVG and stenosis is greatest at 
baseline MVA~4.0cm2 or less. Thus, clinically significant stenosis was likely not observed 
in these studies solely due to the size MV samples used. However, real-world use of 
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MitraClip treatment does include patients with FMR, leaflet tethering and smaller baseline 
MVA.21, 48 Recently-published clinical reports have highlighted the importance of 
maintaining efficient forward flow following MV repair in general, and with MitraClip.25, 
40-42, 60 The present in vitro results in part address the need to understand the level of 
forward flow obstruction resulting from various simulated MitraClip placements, in the 
setting of varied leaflet tethering severity, and across a range of baseline mitral annular 
areas where MS may be a concern. 
6.7 Clinical Implications 
Appropriate selection of patients for successful treatment of MR with repair devices 
is critical to patient outcomes.7 The original Alfieri stitch was originally not intended for 
use without a stabilizing annuloplasty ring, though MitraClip alone has been applied with 
great success.13, 22 Use of the device to treat FMR, where disease of the ventricle is the 
underlying pathology, is now being studied in large-scale clinical trials. However, we have 
shown that altered leaflet functional, namely restricted leaflet opening in diastole, can have 
an effect on the resulting severity of mitral stenosis after simulated MitraClip. Recently, a 
similar clinical study from Kubota and colleagues has shown that severe leaflet tethering 
in FMR can cause MS in patients treated with mitral annuloplasty.49 In the interest of 
improving patient outcomes, analogous investigations in transcatheter repair of FMR are 
necessary to determine the which FMR patients will be suitable not only for MitraClip, but 






General limitations of the GT Left Heart Simulator have been previously 
described.50 In addition, a prototype GTclip was used in place of a MitraClip. Though the 
MitraClip bite profile was carefully replicated, actual MitraClip dynamics may differ. 
Third, MR was not created in this model. MV samples were sufficiently robust, and coapted 
even with severe PM displacement. However, all findings were made during the diastolic 
phase of the cardiac cycle.  Though presence of MR in systole may indeed affect the filling 
dynamics of the LV, LV inflow volume was held constant at 70 mL per beat for all 
experimental cases. Next, simplified and idealized analysis of fluid force on a narrowing 
pipe bend was assumed to estimate the force of fluid on the MV apparatus in diastole. This 
simplified assumption was made given the boundary conditions available. This actual force 
may vary, but comparisons and trends between conditions are valid. Finally, the MVA 
measurement challenges were noted above; nevertheless, the in vitro MVA and MVG 
results presented here agree well with those results observed in published clinical data. 
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CHAPTER 7: CONCLUSIONS 
These results demonstrate that diastolic AML tethering can have a significant impact both 
on MS severity, as well as the increase in MV gradient after GTclip placement. Moderate 
MS occurred at a higher rate with severe AML tethering than with mild or moderate 
tethering (46% versus 4%, respectively). However, the model identified 4.7 cm2 as the 
MAA above which severe AML tethering did not cause moderate MS (placement of up to 
two GTclips, 95% confidence). At this MAA, the mean baseline MVA was 3.9±0.3 cm2 
(at 45°), showing that, while MS was more frequent with severe AML tethering, the 
established MVA cutoff of 4.0 cm2 was applicable for these findings.  
A significant increase in force on the MV apparatus was also observed with severe AML 
tethering and MS. This increased force creates an increased diastolic tension in the mitral 
leaflets. Implications of this on long-term durability are not yet clear, but altered leaflet 
stress has been related to tissue remodeling.  
These conclusions are derived from in vitro testing, which compared favorably to baseline 
and post-clip results in FMR patients. Severity of AML tethering may be an important 
criterion in selecting patients for edge-to-edge repair. 
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CHAPTER 8: FUTURE WORK 
Transcatheter mitral valve repair is an ever-growing and ever-challenging endeavor.7 
MitraClip and transcatheter edge-to-edge repair are the safest available options, but lack 
effectiveness; MR often cannot be completely eliminated and patients are often left with 
MR levels as high as 2+.61 Toward the goal of complete MR reduction using this technique, 
further investigations into the effectiveness of edge-to-edge repair must take place. 
Additionally, increasing focus and attention is being paid to “The Forgotten Valve” or the 
tricuspid valve.62 Further investigations into MitraClip efficacy in treating tricuspid 
regurgitation (TR) could provide valuable data at a much earlier stage of device use. 
8.1 MitraClip in FMR 
8.1.1 Leaflet Strain/Damage 
The edge-to-edge repair devices places stress on the mitral leaflets after 
deployment. Cases of leaflet perforation and MitraClip detachment have been reported.63 
It is unclear if leaflet tethering characteristic of FMR  may cause a greater likelihood of 
this adverse event occurring. Investigation into effect of MitraClip placement on MV 
leaflet stress/strain in the setting of FMR and leaflet tethering could provide useful 
information. 
8.1.2 Efficacy of MitraClip in Type IIIb Systolic Tethering 
Under conditions of Type IIIb systolic tethering and severe FMR, effectiveness of 
MitraClip may be highly dependent on the positioning of the device. Because the MV 
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apparatus is under a larger tension, the effect of the MitraClip on MV coaptation may differ 
from conventional use in DMR patients. Investigation of optimal device placement in the 
setting of varied FMR etiologies would shed light on this issue. 
8.1.3 Towards a Predictive Model and Decision Making Tool 
The statistical model presented herein can readily be applied to clinical data in the 
same way. Incorporating the same variables in a clinical model could yield a robust tool 
which may be applicable in assessment of patient suitability for MitraClip treatment.  
8.2 MitraClip in the Tricuspid Valve 
8.2.1 Use of MitraClip in FTR 
Use of MitraClip to treat FTR is currently gaining clinical traction, but many issues, 
including patient selection and FTR quantification remain.62 Recent studies have 
investigated effectiveness of MitraClip in reducing FTR using an ex vivo model.64 
Additional parametric investigations of use of MitraClip in the right heart may shed light 






APPENDIX A. SUPPLEMENTARY DATA 
A-1 Summary of AML tether angles observed in clinical human data,47 in a pilot 
repeatability test, and over the course of all experiments (N=6). This data was 
used to create Figure 5-2. 
 
Summary of AML Tether Angles (Degrees) 
Angle Target Measure Pilot Experimental Clinical 
75 Degrees 
(Mild) 
Mean 76.55 75.20 74.00 
SD 2.33 2.25 9.00 
60 Degrees 
(Moderate) 
Mean 59.47 60.73 67.00 
SD 2.80 2.05 10.00 
45 Degrees 
(Severe) 
Mean 48.10 45.13 41.00 




A-2 Estimations and 95% confidence intervals (95%CI) for MV area, and 
mean/peak MV gradient.  
Table A-2-1 – Estimates and 95% confidence intervals (CI) for pre-GTclip mitral 
valve area (MVA) under severe anterior mitral leaflet (AML) tethering. Additionally, 
mean MVG and peak MVG estimates and 95%CIs after placement of central and 
commissural GTclips with severe AML tethering. All values calculated as a function 
of mitral annular area (MAA). Data used for Figure 5-3 C-D. 





(mmHg) Peak Grad (mmHg) 
MAA (cm^2) Est. +CI -CI Est. +CI -CI Est. +CI -CI 
3.5 3.1 3.2 2.9 6.2 6.5 5.9 10.8 11.4 10.1 
3.6 3.2 3.3 3.0 6.1 6.4 5.7 10.5 11.2 9.8 
3.7 3.2 3.4 3.1 5.9 6.3 5.5 10.3 11.0 9.5 
3.8 3.3 3.5 3.1 5.7 6.1 5.3 10.0 10.8 9.2 
3.9 3.4 3.6 3.2 5.6 6.0 5.1 9.8 10.6 8.9 
4 3.4 3.6 3.2 5.4 5.9 4.9 9.5 10.4 8.6 
4.1 3.5 3.7 3.3 5.2 5.7 4.7 9.3 10.2 8.3 
4.2 3.6 3.8 3.3 5.1 5.6 4.6 9.0 10.0 8.0 
4.3 3.6 3.9 3.4 4.9 5.4 4.4 8.8 9.8 7.7 
4.4 3.7 3.9 3.4 4.7 5.3 4.2 8.5 9.6 7.4 
4.5 3.7 4.0 3.5 4.6 5.2 4.0 8.2 9.4 7.1 
4.6 3.8 4.1 3.5 4.4 5.0 3.8 8.0 9.2 6.8 
4.7 3.9 4.2 3.6 4.2 4.9 3.6 7.7 9.0 6.5 
4.8 3.9 4.3 3.6 4.1 4.7 3.4 7.5 8.8 6.1 
4.9 4.0 4.3 3.7 3.9 4.6 3.2 7.2 8.7 5.8 
5 4.1 4.4 3.7 3.7 4.5 3.0 7.0 8.5 5.5 
Table A-2-2 – Coefficients and 95% confidence intervals pulled from  
Table 5-1, which were used to calculate the values in Table A-2-1 as demonstrated in 
Equation 5. All coefficient units are in the units of their respective measurements. 
    Coefficients 
Measure Const MAA Clip AML 
Mean 
MVG 
val 3.8129 -1.658 0.953 0.6312 
-e 3.705 -1.932 0.749 0.4872 
+e 3.921 -1.384 1.157 0.7753 
Peak 
MVG 
val 6.875 -2.505 1.647 0.98 
-e 6.659 -3.052 1.24 0.692 
+e 7.09 -1.958 2.055 1.268 
MVA 
val 2.21 0.65 1.53 -0.32 
-e 2.16 0.53 1.44 -0.39 
+e 2.26 0.78 1.62 -0.25 
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A-3 Mean MV Gradient and Significant Differences at Mitral Annular Area of 
4.15cm2 
Table A-3 – Mean MV gradient values displayed in Figure 5-4A. The top section of 
the table shows the mean MVG values along with SE and 95%CI for each 
combination of GTclip placement and AML tether angle. The second section shows 
the change in these values from baseline pre-clip. The third section shows a count of 
the number of MV samples found have MVG>4mmHg in the first row and the 
number that were moderately stenotic (MVG>5mmHg) in the second row (N=6 per 
column). The final section of the table shows the p value for each possible comparison 
of row v. column. Significant p values are highlighted red. 
GTclip Placement No Clip Single Commissure Single Central Double Central Central+ Commissure 
Tether Angle (Degrees) 75 60 45 75 60 45 75 60 45 75 60 45 75 60 45 
Mean Gradient (mmHg) 2.4 2.5 3.0 2.9 2.9 3.8 3.3 3.4 4.2 3.8 3.9 4.8 4.1 4.2 5.2 
Std. Error 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
95% Conf. Interval 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
Mean increase from baseline (mmHg)   0.5 0.3 0.8 1.0 0.9 1.2 1.5 1.4 1.8 1.8 1.7 2.2 
Std. Error       0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
95% Conf. Interval       0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
No. >4mmHg (of 6) 0 0 0 0 0 2 1 1 3 3 3 4 3 4 5 
No. Stenotic (>5mmHg) (of 6) 0 0 0 0 0 1 0 0 2 0 0 4 1 1 4 
Freq. Stenotic 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 0.2 0.2 0.7 
P Values (Column v. Row)                               
No Clip, 75 Deg.   1.000 0.494 0.790 0.788 0.000 0.076 0.021 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 60 Deg.     0.868 0.983 0.983 0.002 0.288 0.107 0.000 0.001 0.000 0.000 0.000 0.000 0.000 
No Clip, 45 Deg.       1.000 1.000 0.246 1.000 0.981 0.002 0.199 0.073 0.000 0.008 0.002 0.000 
Single Commissure, 75 Deg.         1.000 0.086 0.982 0.846 0.000 0.066 0.020 0.000 0.002 0.000 0.000 
Single Commissure, 60 Deg.           0.087 0.983 0.848 0.000 0.066 0.020 0.000 0.002 0.000 0.000 
Single Commissure, 45 Deg.             0.851 0.984 0.914 1.000 1.000 0.015 0.994 0.941 0.000 
Single Central, 75 Deg.               1.000 0.037 0.797 0.515 0.000 0.126 0.047 0.000 
Single Central, 60 Deg.                 0.128 0.970 0.827 0.000 0.339 0.157 0.000 
Single Central, 45 Deg.                   0.945 0.996 0.669 1.000 1.000 0.054 
Double Central, 75 Deg.                     1.000 0.020 0.997 0.964 0.000 
Double Central, 60 Deg.                   0.000   0.067 1.000 0.998 0.001 
Double Central, 45 Deg.                         0.350 0.609 0.985 
Central+Comm, 75 Deg.                           1.000 0.015 
Central+Comm, 60 Deg.                             0.043 
Central+Comm, 45 Deg.                               
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A-4 Peak MV Gradient and Significant Differences at Mitral Annular Area of 
4.15cm2 
Table A-4 – Peak MV gradient values displayed in Figure 5-4B. The top section of the 
table shows the mean values along with SE and 95%CI for each combination of 
GTclip placement and AML tether angle. The second section shows the change in 
these values from baseline pre-clip. The final section of the table shows the p value 
for each possible comparison of row v. column. Significant p values are highlighted 
red. 
GTclip Placement No Clip Single Commissure Single Central Double Central Central+ Commissure 
Tether Angle (Degrees) 75 60 45 75 60 45 75 60 45 75 60 45 75 60 45 
Peak Gradient (mmHg) 4.9 5.1 5.5 5.4 5.4 6.7 5.9 6.1 7.5 6.8 6.9 8.5 7.4 7.6 9.6 
Std. Error 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
95% Conf. Interval 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 
Mean increase from baseline (mmHg)   0.6 0.3 1.3 1.3 1.2 2.1 2.1 2.0 3.1 2.8 2.7 4.2 
Std. Error       0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 
95% Conf. Interval       0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 
P Values (Column v. Row)                               
No Clip, 75 Deg.   1.000 0.999 1.000 1.000 0.120 0.871 0.718 0.002 0.082 0.047 0.000 0.003 0.001 0.000 
No Clip, 60 Deg.     1.000 1.000 1.000 0.317 0.986 0.938 0.008 0.237 0.151 0.000 0.012 0.005 0.000 
No Clip, 45 Deg.       1.000 1.000 0.634 1.000 0.998 0.027 0.522 0.376 0.000 0.041 0.017 0.000 
Single Commissure, 75 Deg.         1.000 0.567 1.000 0.995 0.020 0.456 0.318 0.000 0.031 0.013 0.000 
Single Commissure, 60 Deg.           0.529 1.000 0.993 0.017 0.420 0.288 0.000 0.027 0.011 0.000 
Single Commissure, 45 Deg.             0.985 0.998 0.974 1.000 1.000 0.117 0.990 0.944 0.000 
Single Central, 75 Deg.               1.000 0.231 0.963 0.902 0.002 0.308 0.167 0.000 
Single Central, 60 Deg.                 0.392 0.994 0.975 0.005 0.492 0.301 0.000 
Single Central, 45 Deg.                   0.991 0.998 0.927 1.000 1.000 0.024 
Double Central, 75 Deg.                     1.000 0.169 0.997 0.975 0.000 
Double Central, 60 Deg.                       0.266 1.000 0.994 0.001 
Double Central, 45 Deg.                         0.870 0.964 0.749 
Central+Comm, 75 Deg.                           1.000 0.015 
Central+Comm, 60 Deg.                             0.037 





A-5 Mitral Valve Area and Significant Differences at Mitral Annular Area of 
4.15cm2 
Table A-5 – MV area values displayed in Figure 5-4C. The top section of the table 
shows the mean values along with SE and 95%CI for each combination of GTclip 
placement and AML tether angle. The second section shows the change in these values 
from baseline pre-clip. The final section of the table shows the p value for each 
possible comparison of row v. column. Significant p values are highlighted red. 
 
GTclip Placement No Clip Single Commissure Single Central Double Central Central+Commissure 
Tether Angle (Degrees) 75 60 45 75 60 45 75 60 45 75 60 45 75 60 45 
MVA (cm^2) 4.0 3.9 3.6 2.5 2.4 1.9 2.6 2.2 1.7 2.0 1.9 1.5 1.6 1.5 1.2 
Std. Error 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
95% Conf. Interval 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Mean increase from baseline (cm^2)   1.5 1.5 1.7 1.5 1.6 1.8 2.0 2.0 2.1 2.5 2.4 2.4 
Std. Error       0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
95% Conf. Interval       0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
P Values (Column v. Row)                               
No Clip, 75 Deg.   0.992 0.045 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 60 Deg.     0.633 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 45 Deg.       0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Single Commissure, 75 Deg.         0.989 0.000 1.000 0.509 0.000 0.011 0.000 0.000 0.000 0.000 0.000 
Single Commissure, 60 Deg.           0.019 0.977 0.999 0.001 0.349 0.030 0.000 0.000 0.000 0.000 
Single Commissure, 45 Deg.             0.000 0.284 0.999 0.997 1.000 0.273 0.672 0.236 0.000 
Single Central, 75 Deg.               0.429 0.000 0.008 0.000 0.000 0.000 0.000 0.000 
Single Central, 60 Deg.                 0.019 0.955 0.373 0.000 0.000 0.000 0.000 
Single Central, 45 Deg.                   0.627 0.996 0.919 0.998 0.892 0.007 
Double Central, 75 Deg.                     0.999 0.012 0.073 0.010 0.000 
Double Central, 60 Deg.                       0.201 0.566 0.171 0.000 
Double Central, 45 Deg.                         1.000 1.000 0.502 
Central+Comm, 75 Deg.                           1.000 0.165 
Central+Comm, 60 Deg.                             0.554 





A-6 Fluid Force on the Mitral Valve and Significant Differences 
Table A-6 – Fluid force and drag force values displayed in Figure 5-7. The top section 
of the table shows the mean total fluid force values along with SE and 95%CI for each 
combination of GTclip placement and AML tether angle. The final section of the table 
shows the p value for each possible comparison of row v. column. Significant p values 
are highlighted red. 
 
GTclip Placement No Clip Single Commissure Single Central Double Central Central+Commissure 
Tether Angle (Degrees) 75 60 45 75 60 45 75 60 45 75 60 45 75 60 45 
Total Force (N) 0.47 0.74 1.03 0.79 0.93 1.18 0.81 0.99 1.23 0.97 1.08 1.31 1.10 1.18 1.40 
Std. Error 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
95% Conf. Interval 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 
P Values (Column v. Row)                               
No Clip, 75 Deg.   0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 60 Deg.     0.000 0.987 0.000 0.000 0.818 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 45 Deg.       0.000 0.427 0.010 0.000 0.998 0.000 0.975 0.986 0.000 0.891 0.012 0.000 
Single Commissure, 75 Deg.         0.031 0.000 1.000 0.000 0.000 0.001 0.000 0.000 0.000 0.000 0.000 
Single Commissure, 60 Deg.           0.000 0.144 0.982 0.000 0.999 0.015 0.000 0.004 0.000 0.000 
Single Commissure, 45 Deg.             0.000 0.000 0.981 0.000 0.346 0.076 0.628 1.000 0.000 
Single Central, 75 Deg.               0.002 0.000 0.007 0.000 0.000 0.000 0.000 0.000 
Single Central, 60 Deg.                 0.000 1.000 0.457 0.000 0.217 0.000 0.000 
Single Central, 45 Deg.                   0.000 0.008 0.835 0.030 0.974 0.003 
Double Central, 75 Deg.                     0.236 0.000 0.091 0.000 0.000 
Double Central, 60 Deg.                       0.000 1.000 0.384 0.000 
Double Central, 45 Deg.                         0.000 0.065 0.490 
Central+Comm, 75 Deg.                           0.670 0.000 
Central+Comm, 60 Deg.                             0.000 







A-7 Drag Force on the Mitral Valve and Significant Differences 
Table A-7 – Drag force values displayed in Figure 5-7. The top section of the table 
shows the mean drag force values along with SE and 95%CI for each combination of 
GTclip placement and AML tether angle. The drag force represents the opposing 
force in the direction of mitral inflow for these combinations. The final section of the 
table shows the p value for each possible comparison of row v. column. Significant p 
values are highlighted red. 
 
GTclip Placement No Clip Single Commissure Single Central Double Central Central+Commissure 
Tether Angle (Degrees) 75 60 45 75 60 45 75 60 45 75 60 45 75 60 45 
Drag (N) 0.37 0.52 0.77 0.77 0.87 1.12 0.79 0.93 1.18 0.96 1.05 1.27 1.09 1.16 1.37 
Std. Error 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 
95% Conf. Interval 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 
P Values (Column v. Row)                               
No Clip, 75 Deg.   0.051 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 60 Deg.     0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
No Clip, 45 Deg.       1.000 0.509 0.000 1.000 0.014 0.000 0.002 0.000 0.000 0.000 0.000 0.000 
Single Commissure, 75 Deg.         0.563 0.000 1.000 0.017 0.000 0.003 0.000 0.000 0.000 0.000 0.000 
Single Commissure, 60 Deg.           0.000 0.893 0.968 0.000 0.721 0.008 0.000 0.000 0.000 0.000 
Single Commissure, 45 Deg.             0.000 0.004 0.963 0.029 0.926 0.045 1.000 1.000 0.000 
Single Central, 75 Deg.               0.082 0.000 0.015 0.000 0.000 0.000 0.000 0.000 
Single Central, 60 Deg.                 0.000 1.000 0.392 0.000 0.036 0.000 0.000 
Single Central, 45 Deg.                   0.000 0.098 0.796 0.648 1.000 0.002 
Double Central, 75 Deg.                     0.789 0.000 0.165 0.001 0.000 
Double Central, 60 Deg.                       0.000 0.999 0.368 0.000 
Double Central, 45 Deg.                         0.006 0.378 0.457 
Central+Comm, 75 Deg.                           0.953 0.000 
Central+Comm, 60 Deg.                             0.000 






A-8 Data for Experimental Results Compared with Published Human Results 
 
Table A-8 – Baseline and post-clip MV area and mean MV gradient values for the 
experimental results presented herein, compared with those reported in Chan et al.48 
Values used to produce Figure 5-8. 
 




Mean 3.83 1.92 
SD 0.31 0.44 
95% CI 0.15 0.46 
Chan et 
al 
Mean 3.60 1.50 
SD 0.60 0.40 




Mean 2.47 3.88 
SD 1.14 1.06 
95% CI 1.20 1.11 
Chan et 
al 
Mean 2.20 4.90 
SD 1.30 1.60 




A-9 Tabulated Data for All Experiments 
A-9.1 Tabulated Data Sections 
The following master data table is split into six sections. The sections are assembled as 
follows to create the master data table in its entirety. The tables on pages 64-69 do not fit 
on one page, and are divided and arranged as shown below. Statistical outliers are marked 
red, and were omitted from analysis 
Section A1 Section B1 Section C1 
Section A2 Section B2 Section C2 
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A-9.2 Table Section A1 
Tether angle legend: 1 – 75; 2 – 60; 3 – 45    GTclip No. legend: 1 – No Clip; 2 – Single 












No Clip Tether75 111 1 1 1 3.90 5.046 
No Clip Tether60 112 1 1 2 3.90 5.000 
No Clip Tether45 113 1 1 3 3.90 4.997 
SingleComm Tether75 121 1 2 1 3.90 5.051 
SingleComm Tether60 122 1 2 2 3.90 5.009 
SingleComm Tether45 123 1 2 3 3.90 5.084 
SingleCentral Tether75 131 1 3 1 3.90 5.066 
SingleCentral Tether60 132 1 3 2 3.90 5.078 
SingleCentral Tether45 133 1 3 3 3.90 5.048 
DualCentral Tether75 141 1 4 1 3.90 5.023 
DualCentral Tether60 142 1 4 2 3.90 5.084 
DualCentral Tether45 143 1 4 3 3.90 5.083 
CentralComm Tether75 151 1 5 1 3.90 5.060 
CentralComm Tether60 152 1 5 2 3.90 5.150 
CentralComm Tether45 153 1 5 3 3.90 5.142 
No Clip Tether75 211 2 1 1 4.37 5.069 
No Clip Tether60 212 2 1 2 4.37 5.034 
No Clip Tether45 213 2 1 3 4.37 5.034 
SingleComm Tether75 221 2 2 1 4.37 5.080 
SingleComm Tether60 222 2 2 2 4.37 5.074 
SingleComm Tether45 223 2 2 3 4.37 5.032 
SingleCentral Tether75 231 2 3 1 4.37 4.996 
SingleCentral Tether60 232 2 3 2 4.37 5.009 
SingleCentral Tether45 233 2 3 3 4.37 5.087 
DualCentral Tether75 241 2 4 1 4.37 5.063 
DualCentral Tether60 242 2 4 2 4.37 5.039 
DualCentral Tether45 243 2 4 3 4.37 5.077 
CentralComm Tether75 251 2 5 1 4.37 5.037 
CentralComm Tether60 252 2 5 2 4.37 5.034 
CentralComm Tether45 253 2 5 3 4.37 4.992 
No Clip Tether75 311 3 1 1 3.63 5.067 
No Clip Tether60 312 3 1 2 3.63 5.040 
No Clip Tether45 313 3 1 3 3.63 5.106 
SingleComm Tether75 321 3 2 1 3.63 4.964 
SingleComm Tether60 322 3 2 2 3.63 4.960 
SingleComm Tether45 323 3 2 3 3.63 4.957 
SingleCentral Tether75 331 3 3 1 3.63 5.111 
SingleCentral Tether60 332 3 3 2 3.63 4.995 
SingleCentral Tether45 333 3 3 3 3.63 4.975 
DualCentral Tether75 341 3 4 1 3.63 4.965 
DualCentral Tether60 342 3 4 2 3.63 4.941 
DualCentral Tether45 343 3 4 3 3.63 4.997 
CentralComm Tether75 351 3 5 1 3.63 5.025 
CentralComm Tether60 352 3 5 2 3.63 5.059 
CentralComm Tether45 353 3 5 3 3.63 5.129 
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A-9.3 Table Section A2 
No Clip Tether75 411 4 1 1 3.99 4.938 
No Clip Tether60 412 4 1 2 3.99 4.940 
No Clip Tether45 413 4 1 3 3.99 4.927 
SingleComm Tether75 421 4 2 1 3.99 5.032 
SingleComm Tether60 422 4 2 2 3.99 4.973 
SingleComm Tether45 423 4 2 3 3.99 4.997 
SingleCentral Tether75 431 4 3 1 3.99 5.063 
SingleCentral Tether60 432 4 3 2 3.99 5.112 
SingleCentral Tether45 433 4 3 3 3.99 5.095 
DualCentral Tether75 441 4 4 1 3.99 4.930 
DualCentral Tether60 442 4 4 2 3.99 5.097 
DualCentral Tether45 443 4 4 3 3.99 5.175 
CentralComm Tether75 451 4 5 1 3.99 4.958 
CentralComm Tether60 452 4 5 2 3.99 4.938 
CentralComm Tether45 453 4 5 3 3.99 5.075 
No Clip Tether75 511 5 1 1 4.09 4.987 
No Clip Tether60 512 5 1 2 4.09 4.956 
No Clip Tether45 513 5 1 3 4.09 5.043 
SingleComm Tether75 521 5 2 1 4.09 5.054 
SingleComm Tether60 522 5 2 2 4.09 4.920 
SingleComm Tether45 523 5 2 3 4.09 5.084 
SingleCentral Tether75 531 5 3 1 4.09 4.928 
SingleCentral Tether60 532 5 3 2 4.09 4.914 
SingleCentral Tether45 533 5 3 3 4.09 4.983 
DualCentral Tether75 541 5 4 1 4.09 4.956 
DualCentral Tether60 542 5 4 2 4.09 4.948 
DualCentral Tether45 543 5 4 3 4.09 5.030 
CentralComm Tether75 551 5 5 1 4.09 5.046 
CentralComm Tether60 552 5 5 2 4.09 4.939 
CentralComm Tether45 553 5 5 3 4.09 5.124 
No Clip Tether75 311 6 1 1 4.80 5.054 
No Clip Tether60 312 6 1 2 4.80 5.007 
No Clip Tether45 313 6 1 3 4.80 4.997 
SingleComm Tether75 321 6 2 1 4.80 5.147 
SingleComm Tether60 322 6 2 2 4.80 5.111 
SingleComm Tether45 323 6 2 3 4.80 5.221 
SingleCentral Tether75 331 6 3 1 4.80 5.052 
SingleCentral Tether60 332 6 3 2 4.80 5.095 
SingleCentral Tether45 333 6 3 3 4.80 5.068 
DualCentral Tether75 341 6 4 1 4.80 5.106 
DualCentral Tether60 342 6 4 2 4.80 5.119 
DualCentral Tether45 343 6 4 3 4.80 5.155 
CentralComm Tether75 351 6 5 1 4.80 5.136 
CentralComm Tether60 352 6 5 2 4.80 5.176 






















118.793 2.070   3.686   0   
119.598 2.875   4.662   0   
118.085 3.378   5.159   0   
122.138 3.479 1.409 5.511 1.825 0 0 
119.542 3.341 0.466 5.322 0.660 0 0 
121.944 5.722 2.344 8.893 3.734 1 1 
121.350 4.189 2.119 6.861 3.175 0 1 
121.330 4.397 1.522 7.257 2.595 0 1 
120.960 5.815 2.437 9.172 4.013 1 1 
120.549 4.277 2.207 7.314 3.628 0 1 
118.611 4.855 1.980 8.133 3.471 0 1 
121.591 5.764 2.386 9.811 4.652 1 1 
119.616 4.334 2.264 7.625 3.939 0 1 
118.551 4.509 1.634 7.864 3.202 0 1 
121.057 6.050 2.672 10.288 5.129 1 1 
119.943 0.791   2.217   0   
118.818 0.563   2.224   0   
120.076 2.495   4.125   0   
120.527 2.789  4.457 2.240 0 0 
121.425 2.797  4.485 2.261 0 0 
120.763 3.391 0.896 5.516 1.391 0 0 
120.143 2.436  3.892 1.675 0 0 
121.943 2.770  4.326 2.102 0 0 
121.798 3.528 1.033 5.989 1.864 0 0 
121.480 3.149  5.088 2.871 0 0 
120.383 3.154  5.072 2.848 0 0 
121.744 3.706 1.211 6.129 2.004 0 0 
117.527 3.389  5.485 3.268 0 0 
119.936 3.386  5.549 3.325 0 0 
119.260 4.254 1.759 6.824 2.699 0 1 
119.091 2.931   5.705   0   
119.328 2.864   5.551   0   
120.744 3.702   6.436   0   
119.417 3.280 0.349 5.513 -0.192 0 0 
120.382 3.323 0.459 5.607 0.056 0 0 
119.746 4.392 0.690 7.824 1.388 0 1 
120.666 3.970 1.039 7.023 1.318 0 0 
120.855 3.861 0.997 6.910 1.359 0 0 
120.177 5.061 1.359 9.307 2.871 1 1 
120.635 4.432 1.501 8.080 2.375 0 1 
118.976 4.397 1.533 8.012 2.461 0 1 
119.901 5.421 1.719 9.637 3.201 1 1 
121.711 4.955 2.024 9.706 4.001 1 1 
120.873 5.061 2.197 10.081 4.530 1 1 
118.621 7.213  13.687 7.251 1 1 
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A-9.5 Table Section B2 
120.859 2.565   5.147   0   
119.588 2.564   5.225   0   
122.194 3.060   5.545   0   
119.909 2.638 0.073 5.681 0.534 0 0 
124.823 2.762 0.198 5.572 0.347 0 0 
119.908 3.116 0.056 5.837 0.292 0 0 
120.292 3.729 1.164 6.498 1.351 0 0 
120.909 3.894 1.330 6.709 1.484 0 0 
117.152 4.355 1.295 7.748 2.203 0 1 
121.940 3.517 0.952 6.361 1.214 0 0 
121.459 3.765 1.201 6.931 1.706 0 0 
118.926 5.283 2.223 9.875 4.330 1 1 
120.050 3.934 1.369 7.370 2.223 0 0 
119.943 4.266 1.702 7.889 2.664 0 1 
119.073 5.626 2.566 10.241 4.696 1 1 
119.767 2.688   5.817   0   
120.981 2.761   5.877   0   
120.785 3.479   6.345   0   
120.660 3.024 0.336 6.406 0.589 0 0 
120.728 3.005 0.244 6.304 0.427 0 0 
119.853 3.335 -0.144 6.592 0.247 0 0 
119.998 3.022 0.334 6.136 0.319 0 0 
119.829 3.008 0.247 6.043 0.166 0 0 
120.506 3.619 0.140 7.033 0.688 0 0 
121.665 4.485 1.797 8.233 2.416 0 1 
120.897 4.471 1.710 7.967 2.090 0 1 
119.755 5.098 1.619 8.974 2.629 1 1 
119.728 4.700 2.012 8.280 2.463 0 1 
122.279 4.704 1.943 8.189 2.312 0 1 
121.173 5.242 1.763 9.073 2.728 1 1 
122.788 1.876   4.412   0   
124.108 1.870   4.778   0   
124.256 1.993   5.020   0   
121.681 2.177 0.301 4.745 0.333 0 0 
122.702 2.165 0.295 4.846 0.067 0 0 
121.890 2.598 0.605 5.411 0.391 0 0 
121.712 2.261 0.385 5.036 0.624 0 0 
122.678 2.421 0.551 5.155 0.376 0 0 
123.965 2.886 0.894 5.755 0.735 0 0 
121.707 2.854 0.978 5.524 1.112 0 0 
121.901 2.731 0.861 5.205 0.426 0 0 
121.969 3.414 1.421 6.217 1.197 0 0 
120.608 3.220 1.344 6.046 1.635 0 0 
120.630 3.203 1.334 5.935 1.156 0 0 








A-9.6 Table Section C1 
Mitral Valve Area (cm^2) Fluid Force on MV (N) 















3.95 3.99 3.96 3.97   0.02 IM_0050 0.28 0.28 0.393 
3.95 3.71 3.92 3.86   0.13 IM_0048 0.45 0.52 0.688 
3.48 3.22 3.54 3.41   0.17 IM_0052 0.71 0.65 0.963 
2.22 2.64 2.71 2.52 -1.443 0.27 IM_0073 0.71 0.18 0.730 
2.39 2.32 2.37 2.36 -1.500 0.04 IM_0071 0.80 0.33 0.861 
1.63 1.85 1.89 1.79 -1.623 0.14 IM_0069 1.17 0.36 1.225 
2.41 2.27 2.38 2.35 -1.613 0.07 IM_0060 0.82 0.17 0.833 
2.33 2.34 2.07 2.25 -1.613 0.15 IM_0058 0.92 0.31 0.971 
1.82 1.80 1.57 1.73 -1.683 0.14 IM_0056 1.19 0.35 1.245 
1.78 1.88 1.85 1.84 -2.130 0.05 IM_0066 0.95 0.14 0.964 
1.75 1.54 1.63 1.64 -2.220 0.11 IM_0064 1.08 0.24 1.110 
1.26 1.34 1.53 1.38 -2.037 0.14 IM_0062 1.28 0.29 1.315 
1.55 1.50 1.39 1.48 -2.487 0.08 IM_0079 1.05 0.11 1.053 
1.51 1.46 1.42 1.46 -2.397 0.05 IM_0077 1.10 0.22 1.125 
1.27 1.23 1.37 1.29 -2.123 0.07 IM_0075 1.32 0.28 1.348 
4.37 4.40 4.22 4.33   0.10 IM_0095 0.25 0.30 0.393 
4.21 3.97 4.03 4.07   0.12 IM_0096 0.42 0.55 0.688 
3.68 3.52 3.92 3.71   0.20 IM_0097 0.75 0.71 1.031 
2.58 2.48 2.48 2.51 -1.817 0.06 IM_0106 0.80 0.18 0.824 
2.39 2.21 2.32 2.31 -1.763 0.09 IM_0105 0.91 0.32 0.968 
1.88 1.83 1.81 1.84 -1.867 0.04 IM_0104 1.14 0.37 1.202 
2.98 2.86 2.82 2.89 -1.443 0.08 IM_0100 0.69 0.20 0.716 
2.16 2.52 2.40 2.36 -1.710 0.18 IM_0099 0.89 0.33 0.951 
1.84 1.88 1.94 1.89 -1.820 0.05 IM_0098 1.16 0.38 1.224 
2.47 2.54 2.67 2.56 -1.770 0.10 IM_0103 0.83 0.18 0.850 
2.23 2.33 2.15 2.24 -1.833 0.09 IM_0102 0.96 0.31 1.010 
2.09 1.95 1.76 1.93 -1.773 0.17 IM_0101 1.16 0.39 1.227 
1.95 1.73 1.80 1.83 -2.503 0.11 IM_0109 1.02 0.13 1.027 
1.74 1.82 1.74 1.77 -2.303 0.05 IM_0108 1.08 0.25 1.111 
1.50 1.50 1.49 1.50 -2.210 0.01 IM_0107 1.27 0.31 1.311 
3.52 3.56 3.43 3.50   0.07 IM_0128 0.40 0.25 0.469 
3.32 3.51 3.37 3.40   0.10 IM_0126 0.50 0.46 0.681 
3.11 3.34 3.19 3.21   0.12 IM_0127 0.71 0.62 0.943 
2.33 2.34 2.32 2.33 -1.173 0.01 IM_0141 0.66 0.17 0.682 
2.20 2.36 2.24 2.27 -1.133 0.08 IM_0140 0.74 0.32 0.803 
1.44 1.55 1.52 1.50 -1.710 0.06 IM_0138 1.06 0.31 1.106 
2.51 2.58 2.29 2.46 -1.043 0.15 IM_0134 0.70 0.18 0.725 
2.24 2.26 2.29 2.26 -1.137 0.03 IM_0133 0.80 0.31 0.861 
1.43 1.53 1.41 1.46 -1.757 0.06 IM_0132 1.14 0.31 1.180 
1.76 1.53 1.58 1.62 -1.880 0.12 IM_0137 0.94 0.12 0.948 
1.47 1.86 1.60 1.64 -1.757 0.20 IM_0136 0.98 0.24 1.006 
1.18 1.37 1.05 1.20 -2.013 0.16 IM_0135 1.19 0.27 1.222 
1.37 1.41 1.28 1.35 -2.150 0.07 IM_0154 1.07 0.11 1.079 
1.34 1.49 1.23 1.35 -2.047 0.13 IM_0153 1.13 0.20 1.149 





A-9.7 Table Section C2 
3.70 3.92 3.78 3.80   0.11 IM_0160 0.42 0.26 0.498 
3.58 3.60 3.51 3.56   0.05 IM_0158 0.57 0.48 0.747 
3.22 3.42 3.50 3.38   0.14 IM_0159 0.76 0.65 1.000 
2.41 2.30 2.21 2.31 -1.493 0.10 IM_0169 0.79 0.17 0.812 
2.04 2.20 2.03 2.09 -1.473 0.10 IM_0168 0.89 0.29 0.939 
1.87 1.96 1.79 1.87 -1.507 0.09 IM_0167 1.03 0.38 1.095 
2.33 2.13 2.10 2.19 -1.613 0.13 IM_0163 0.86 0.16 0.879 
1.78 1.99 1.92 1.90 -1.667 0.11 IM_0162 0.99 0.27 1.027 
1.74 1.79 1.67 1.73 -1.647 0.06 IM_0161 1.15 0.35 1.205 
1.81 1.91 1.91 1.88 -1.923 0.06 IM_0166 0.93 0.14 0.937 
1.70 1.69 1.74 1.71 -1.853 0.03 IM_0165 1.04 0.25 1.068 
1.41 1.55 1.51 1.49 -1.890 0.07 IM_0164 1.30 0.31 1.339 
1.46 2.16 1.67 1.76 -2.037 0.36 IM_0172 1.00 0.13 1.013 
1.36 1.34 1.27 1.32 -2.240 0.05 IM_0171 1.16 0.20 1.179 
1.06 1.15 1.16 1.12 -2.257 0.06 IM_0170 1.37 0.25 1.398 
3.81 3.99 4.05 3.95   0.12 IM_0188 0.46 0.28 0.533 
3.80 3.91 3.79 3.83   0.07 IM_0189 0.58 0.52 0.779 
3.38 3.54 3.61 3.51   0.12 IM_0190 0.82 0.67 1.057 
1.89 1.97 1.98 1.95 -2.003 0.05 IM_0200 0.95 0.14 0.959 
1.98 1.99 1.80 1.92 -1.910 0.11 IM_0199 1.00 0.27 1.035 
1.54 1.57 1.54 1.55 -1.960 0.02 IM_0198 1.15 0.32 1.198 
2.46 2.59 2.46 2.50 -1.447 0.08 IM_0193 0.81 0.18 0.828 
2.24 2.31 2.25 2.27 -1.567 0.04 IM_0192 0.92 0.32 0.968 
1.69 1.81 1.70 1.73 -1.777 0.07 IM_0191 1.15 0.35 1.202 
1.86 1.69 1.85 1.80 -2.150 0.10 IM_0197 1.08 0.13 1.087 
1.64 1.69 1.69 1.67 -2.160 0.03 IM_0196 1.14 0.24 1.163 
1.41 1.47 1.30 1.39 -2.117 0.09 IM_0194 1.31 0.30 1.340 
1.32 1.22 1.26 1.27 -2.683 0.05 IM_0203 1.19 0.10 1.197 
1.21 1.20 1.19 1.20 -2.633 0.01 IM_0202 1.24 0.19 1.250 
1.05 1.07 1.16 1.09 -2.417 0.06 IM_0201 1.35 0.25 1.378 
4.70 4.59 4.73 4.67   0.07 IM_0204 0.44 0.32 0.544 
4.55 4.52 4.39 4.49   0.09 IM_0205 0.62 0.60 0.861 
4.19 4.24 4.32 4.25   0.07 IM_0206 0.85 0.81 1.172 
3.60 3.70 3.56 3.62 -1.053 0.07 IM_0213 0.71 0.25 0.749 
3.20 3.41 3.13 3.25 -1.240 0.15 IM_0214 0.88 0.44 0.984 
2.77 2.48 2.72 2.66 -1.593 0.16 IM_0215 1.15 0.52 1.257 
2.85 2.98 2.99 2.94 -1.733 0.08 IM_0207 0.88 0.21 0.905 
2.35 2.24 2.40 2.33 -2.157 0.08 IM_0208 1.09 0.32 1.136 
1.95 1.69 1.89 1.84 -2.407 0.14 IM_0209 1.30 0.37 1.354 
2.49 2.41 2.40 2.43 -2.240 0.05 IM_0210 1.03 0.17 1.043 
2.42 2.42 2.44 2.43 -2.060 0.01 IM_0211 1.07 0.34 1.123 
1.60 1.69 1.67 1.65 -2.597 0.05 IM_0212 1.36 0.34 1.403 
1.87 1.62 1.99 1.83 -2.847 0.19 IM_0216 1.20 0.13 1.205 
1.87 2.01 1.77 1.88 -2.603 0.12 IM_0217 1.23 0.27 1.256 




APPENDIX B. ENGINEERING DRAWINGS 
B-1 Adjustable Annulus Plate Engineering Drawing 
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B-2 GTclip Engineering Drawing 
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APPENDIX C. CATALOG OF DATA STORAGE 
C.1 General Manuals and Guides 
The following documents are stored under: 
\yogi-lab\CFM Transitions\Charlie Transition\MANUALS AND GUIDES 
\Loop Setup and Operation 
GT left and right heart simulator setup and tuning, target 
hemodynamics, loop configuration. 
  \MV Excision and Mounting 
Animal mitral valve excision, prep, annulus suturing, papillary 
muscle prep and fixturing 
  \MicroCT Prep and Scanning 
Scanning mounted mitral valve samples by MicroCT unloaded, 
glutaraldehyde fixed, and under steady pressure. 
  \Heartbeater User Guide 
Setup, operation and troubleshooting of the LabVIEW VI that 
controls GT heart simulators. 
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C.2 Thesis Documents and Data 
The following documents are stored under: 
\yogi-lab\CFM Transitions\Charlie Transition\THESIS 
\CAD 
  \GTclip 
   CAD, CAM and bill of materials for GTclip. 
  \Square Adjustable Annulus 
CAD, CAM and bill of materials for the square adjustable annulus. 
\Data 
  \Hemo 
Contains all hemo recordings gathered for the MitraClip 
experiments. 
  \Summarized Final Data 
Contains master spreadsheet of all final data used in thesis project, 
along with bar graphs. MATLAB programs and Minitab files are 
also included. 
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The library of all echo images can be found on AadiBozz under 
yogi-lab\Mitral Valve Group - Everything\Experimental 
Data\MitraClip_CHB 
 \Dissertation Document 
All files, figures and documents pertaining to the thesis dissertation 
document, including the final, approved document. 
\Figures and Images 
All figures, images and videos made pertaining to the MitraClip 
experiments. Videos are included in GIF format. 
 \Literature 
Important papers and literature. Additional papers can be found in the 
references section of the thesis dissertation 
\Presentation Slides 
Library of all slides and presentations made for the MitraClip project. 
 \Publication – JACC Intervention 2017 
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